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 Neisseria gonorrhoeae, the etiologic agent of gonorrhea, utilizes TonB-dependent 
transporters to import essential nutrients such as iron. Study of TonB-dependent transporters is 
extremely important due to the fact that they make excellent vaccine targets. In order to learn 
more about the structure, function, expression, and regulation of selected TonB-dependent 
transporters, three goals were established for this study. The first goal was to examine the role of 
two highly conserved regions of TbpB in lipidation. One of the conserved regions of TbpB, the 
LSAC motif, was shown to be critical for lipidation. The second goal was to determine whether 
MisR/MisS regulates expression of TbpA and TbpB. MisR/MisS was shown to regulate the 
 
xiii 
 
expression of TbpA and TbpB. The third goal was to assess the ability of recombinant TdfJ to 
bind hemin when expressed in E. coli. Recombinant TdfJ was shown to specifically bind hemin 
when expressed in E. coli. 
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Introduction 
 
 
 
I. Genus Neisseria  
 The genus Neisseria lies within the family Neisseriaceae. The family Neisseriaceae also 
contains the genera Moraxella, Acinetobacter, and Kingella (49). The genus Neisseria is 
comprised of Gram-negative diplococci, ranging from 0.6-1.5 μm in size, occurring in pairs with 
flattened adjacent sides. They are non-motile, except for the twitching mobility caused by pilus 
retraction. Most Neisseria are catalase positive and all Neisseria are oxidase positive. There are 
12 species within the genus Neisseria and the vast majority are commensals that are found as 
part of normal human flora (6). However, Neisseria meningitidis and Neisseria gonorrhoeae are 
obligate human pathogens that cause significant morbidity globally. The two species are very 
similar, although N. meningitidis is encapsulated, whereas N. gonorrhoeae is not. Although N. 
meningitidis causes disease in humans, it is also commonly carried by healthy individuals in the 
nasopharynx (81). However, it can disseminate and cause serious diseases such as 
meningococcaemia and meningococcal meningitis, which have very high mortality rates if 
untreated. The World Health Organization reports that there are 12 serogroups, and of these only 
six are the cause of frequent disease globally. These serogroups are A, B, C, W135, Y and X. 
Currently vaccines are on the market that protect against serogroups A, C, Y, and W-135 and 
  
 2  
  
they have been successful in reducing the burden of disease when implemented on a large scale. 
However, since the introduction of the various vaccines the incidence of meningococcus B has 
been on the rise in many parts of the world (72). However, very recently a multicomponent 
meningococcal group B vaccine was released and has been approved for use in many countries 
(36). Neisseria gonorrhoeae is the etiologic agent of the sexually transmitted disease gonorrhea. 
Infection with gonorrhea is transmitted via intimate sexual contact, however it can also be 
transmitted prenatally (16). There is currently no vaccine available to prevent infection with N. 
gonorrhoeae. The subsequent sections of this thesis will focus exclusively on N. gonorrhoeae. 
II. Neisseria gonorrhoeae 
A. Infection 
 N. gonorrhoeae infects the urogenital or anorectal mucosa of both males and females. 
The gonococcal pilus allows for initial contact with the host cell, and facilitates adhesion, 
invasion, and traversal of monolayers (57). Following initial attachment, pilus retraction allows 
Opa adhesins to create a tight connection with host cell receptors. Attachment then causes 
cytoskeletal rearrangement of the host cell, followed by engulfment of the bacteria (37). After 
invasion, bacteria can persist intracellularly and undergo transcytosis through the epithelia, 
allowing entrance into the subepithelial compartment. This process leads to the establishment of 
localized infection, although disseminated infection can also follow (55).  
B. Disease and Treatment 
 Neisseria gonorrhoeae is the causative agent of the sexually transmitted infection 
gonorrhea. Men generally begin to show signs of infection after an incubation period of 2 to 5 
days. Early symptoms include acute urethritis, purulent discharge, and dysuria (15). Disease in 
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men is generally uncomplicated because the early symptoms cause them to seek medical 
attention. Ascension of the disease in men can lead to epididymitis and prostatitis. In women, 
symptomatic uncomplicated disease presents within 10 days of infection, manifesting as 
urethritis and/or cervicitis. However, it is estimated that up to 80% of infections in women are 
asymptomatic or cause minor symptoms that are ignored (56). Untreated gonococcal infections 
have serious and permanent downstream sequelae, including internal abscesses, chronic pelvic 
pain, and pelvic inflammatory disease (PID) (16). PID is a very serious consequence of untreated 
infection that increases the risk of ectopic pregnancy and leads to infertility in 10-15% of women 
that acquire the disease (17). Although it is rare, life-threatening disseminated infection is also 
possible in both men and women if the infection is left untreated. Symptoms of disseminated 
infection include fever, tenosynovitis, and dermatitis. Perinatal infection can occur if an infected 
mother delivers her child vaginally (16).  
 In contrast to N. meningitidis, there is no vaccine available to prevent infection with N. 
gonorrhoeae. In addition, natural infection with N. gonorrhoeae does not elicit protective 
immunity. The lack of an effective vaccine and protective immunity following infection is due to 
the highly variable cell surface of the gonococci.  
C. Epidemiology 
In 2012 there were 334,826 reported cases in the U.S., making it the second most 
commonly reported notifiable infectious disease in the United States. This number is likely 
inaccurate due to inefficient reporting practices and the CDC estimates that the number of actual 
infections per year could be more than double the number of reported infections (15). Within the 
U.S., infection is most common among young adults and African Americans. Gonococcal 
infections are also prevalent outside of U.S. The World Health Organization estimated that there 
  
 4  
  
were 106.1 million new cases of N. gonorrhoeae in adults worldwide in 2008 (99). Although 
common amongst both men and women, gonococcal infections are slightly more common 
amongst women and cause significantly more morbidity in women due to the high frequency of 
asymptomatic infections.  
D. Antibiotic Resistance 
In 1935 the first curative treatment for gonorrhea was introduced in the form of 
sulphanilamide. However, shortly after its introduction N. gonorrhoeae quickly became resistant 
and the first line treatment recommendation was altered (47). Since then, penicillins, 
tetracyclines, macrolides, fluoroquinolones, and cephalosporins have experienced the same fate. 
In 2012 the CDC released a statement saying that they no longer recommended oral antibiotic 
cefixime as a first-line treatment option (18). Currently, the only recommended first-line 
treatment for gonococcal infection is a single dose of intramuscular ceftriaxone, a third-
generation celphalosporin, along with oral azithromycin (18). In 2011, a ceftriaxone-resistant 
strain of N. gonorrhoeae was isolated from a pharyngeal specimen taken from a Japanese 
commercial sex worker (69). In 2013, the CDC published a report entitled “Antibiotic Resistance 
Threats in the United States.” They categorized pathogens based on the level of threat they posed 
to public health, and drug-resistant N. gonorrhoeae was placed into the “urgent” hazard level 
category, the most serious of the three categories (19). They state that N. gonorrhoeae is “an 
immediate public health threat that requires urgent and aggressive action.” The threat of 
untreatable gonorrhea infection a real possibility, therefore research into possible vaccine targets 
and novel treatments is warranted.   
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E. Vaccine  
 The development of an effective vaccine is imperative due to the aforementioned health 
impacts and increasing antibiotic resistance associated with gonococcal infections. The surface 
of the gonococcus is littered with virulence factors, such as lipooligosaccharide (LOS), pilin, and 
opacity proteins (Opas), which would make logical vaccine targets. However, these surface 
exposed proteins undergo frequent variation that makes this impractical. The gonococcus 
constantly alters its surface exposed components through phase variation and antigenic variation. 
Antigenic variation is the frequent alteration of immunodominant epitopes. Phase variation is a 
reversible “on or off” switch for expression of certain proteins (35). Because of this variation 
gonococcal infection does not impart protective immunity and makes the creation of an effective 
vaccine very difficult. However, there are some surface-exposed proteins that do not undergo 
such significant variation and are consistently on the outer membrane due to their importance to 
the organism. The TonB-dependent transporters (TdTs) are nutrient acquisition systems that are 
ideal candidates for a vaccine due to their consistent expression and well-conserved structures. 
Further research into their possible role in the development of a vaccine is warranted.  
F. Virulence Factors 
 N. gonorrhoeae possesses many important virulence factors that aid in adherence, 
invasion, and immune evasion. Important virulence factors include pili, Opas, LOS, and porin. 
Pili are long filamentous structures that project out of the bacterial outer membrane. Pili are 
composed of a pilin protein subunit, known as PilE, and are capped off by the PilC protein (35). 
This structure is depicted below in Figure 1. Pili are crucial for adherence, colonization of host 
tissue, and DNA uptake (34, 94). Nonpiliated cells are not competent for DNA uptake (10). Pili 
expression is phase variable due to the poly-cytosine tract in pilE (50). Pili expression is also 
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subject to antigenic variation due to nonreciprocal transfer of DNA sequences from one of the 
many silent pilS cassettes into the expressed pilE locus (40).  
 Opas are integral outer membrane proteins, and a single gonococcal strain can possess up 
to 11 different opa alleles. Opa proteins were named because their expression effects colony 
color and opacity (84). Opa proteins have been shown to bind to cell surface heparan sulfate 
proteoglycans (HSPG) or carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 
(55, 78, 92). Opas also play a role in the downregulation of the host immune response towards 
the pathogen (11). Opas are also subject to phase variation due to slipped-strand mispairing. 
Slipped-strand mispairing causes changes in the CTCTT repeats, resulting in a frameshift 
mutation (63). Opas are thought to be important for infection based on the fact that bacteria 
recovered subsequent to successful human infection are usually Opa positive (46). 
 LPS is a common component of gram-negative bacterial outer membranes. N. 
gonorrhoeae produces a shorter form of LPS known as lipooligosaccharide (LOS). LOS is 
anchored to the membrane by the endotoxic lipid A moiety. LOS is phase variable and can 
undergo sialylation. Low levels of LOS sialylation allow for highly efficient entry into human 
mucosal epithelial cells. High levels of LOS sialylation disable the bacteria from entering the 
host cells as efficiently, but enable them to resist killing by complement and antibodies. Thus, 
LOS plays a role in both bacterial entry and immune evasion (37, 98).  
  Porin is the major outer membrane protein expressed by N. gonorrhoeae. Porin is 
essential for bacterial viability, and is therefore not subject to phase variation. All gonococcal 
strains contain the porB gene, and can possess either the porB1a or porB1b allele. porB1a 
encodes the P.1A protein, while porB1b encodes the P.1B protein. Expression of the PIA protein 
has been implicated in invasive disease (38). PorB forms a trimeric, hydrophilic pore across 
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Figure 1. Major virulence factors and morphology of N. gonorrhoeae.  The figure depicts 
the diplococcus, containing the pair of cells with adjacent flattened sides. Depictions of the 
major virulence factors, including pili, Opas, LOS, and porin, are also included. 
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Figure 1. Major virulence factors and morphology of N. gonorrhoeae. 
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the gonococcal membrane, which allows for the diffusion of small hydrophilic molecules (27). 
Porin has been shown to be to be involved in invasion and regulation of apoptosis (38). Factor H 
has been shown to bind to a surface exposed region of P.1A, therefore aiding in serum resistance 
(77). 
III. Iron Acquisition  
 Iron is a nutrient that is absolutely essential to survival for gonococci, as evidenced by its 
many dedicated iron uptake systems. Iron is vital for many cellular functions within bacteria, 
such as growth, RNA synthesis, and DNA synthesis. Iron is also important for bacterial 
metabolism, as it is used in the tricarboxylic acid cycle and oxidative phosphorylation. Iron plays 
an important role in protecting cells against oxidative stress. Catalases and peroxidases, which 
destroy harmful free radicals, contain iron. Many other important proteins and enzymes also 
require iron for proper function (58). Excess free iron is toxic due to the oxidative stress caused 
by hydroxyl radicals that are produced by the Fenton reaction: Fe2+ + H2O2  Fe3+ + OH- + OH. 
Therefore, almost all of the iron present in the host is contained within various high affinity iron-
binding proteins.  
 Some important iron sources available within the host include: transferrin, lactoferrin, 
ferritin, heme, hemoglobin, and siderophores. Transferrin is an 80 kD glycoprotein that is 
capable of binding two atoms of iron (93). Transferrin is present in the serum and helps to 
sequester and transport iron.  Lactoferrin is an 80 kD glycoprotein involved in protective iron 
chelation. Lactoferrin is found in lymph and mucosal secretions. Both transferrin and lactoferrin 
have an exceptionally high affinity for ferric iron. N. gonorrhoeae has been shown to use 
transferrin and lactoferrin as iron sources (59, 60). Ferritin is a cytoplasmic protein consisting of 
24 subunits (93). Ferritin is important for intracellular iron storage and is capable of binding 
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several thousand iron ions. Heme is a protoporphyrin that can bind one ferrous iron ion in its 
center. Solitary heme is very cytotoxic and is therefore not usually found free within the host 
(93). Iron bound to heme is the most abundant form of iron found in vertebrates, and the most of 
the heme is bound to hemoglobin (5). Heme serves as an iron source and is also essential for 
several aerobic processes in bacteria. Most bacteria have a dedicated transport system for heme 
uptake, however one such system has not been identified within N. gonorrhoeae. However, 
utilization of heme as an iron source and as a heme source has been demonstrated in vitro (88). 
Hemoglobin is a tetramer, and each subunit can bind a heme molecule. Hemoglobin is an oxygen 
transporter found in red blood cells. The gonococcus has been shown to use hemoglobin as an 
iron source (31). Siderophores are low molecular weight compounds secreted by many different 
microorganisms for the purpose of iron acquisition. These chelating agents bind ferric iron with 
high affinity and can strip iron from host iron binding proteins (65). After iron is bound, the 
ferrated siderophore can be utilized as an iron source by the organism. N. gonorrhoeae has 
specific iron transport systems that facilitate the use transferrin (24), lactoferrin (9), hemoglobin 
(21), and some heterologous siderophores (97). N. gonorrhoeae does not produce its own 
siderophores, and therefore can only utilize those produced by neighboring bacteria (96). N. 
gonorrhoeae has been shown to utilize aerobactin, enterobactin, and other catecholate 
siderophores including dimers and trimers of dihydroxybenzoylserine and salmochelin S2 (14, 
43, 96).  
A. TonB-Dependent Transport 
 TonB-Dependent transporters (TBDTs) are utilized by Gram-negative bacteria in order to 
access many necessary nutrients. Porins allow for concentration-dependent, and non-specific 
diffusion of solutes smaller than 600 daltons; however, many nutrients required by the gonococci 
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are larger than this (66). The majority of the substrates for TBDT are iron complexes, however 
nickel chelates, carbohydrates, and vitamin B12 are transported in this fashion (67). All known 
TBDTs contain a beta-barrel composed of 22 amphipathic beta-strands and a globular plug 
domain. The globular plug domain is folded up inside of the beta-barrel and functions to bind 
specific substrates (67).  TBDTs interact with a cytoplasmic membrane protein complex 
composed of TonB, ExbB, and ExbD. ExbB an ExbD derive energy from the proton motive 
force of the cytoplasmic membrane and transfer it to TonB, which in turn transfers the energy to 
the outer membrane transporter (70, 75). TonB interacts with components in both the outer and 
cytoplasmic membrane, while ExbB and ExbD are anchored to the cytoplasmic membrane. Both 
ExbB and ExbD are necessary for TonB to respond to proton motive force and are both 
necessary for TonB to associate with the cytoplasmic membrane (42). After the substrate binds 
the receptors and is transported through the channel, the substrate rapidly binds a specific 
periplasmic binding protein. This periplasmic binding protein then shuttles the substrate to ABC 
transporters that are embedded in the cytoplasmic membrane. Finally, the ABC transporter 
transports the substrate into the cytoplasm (32). 
B. Two Component TonB-Dependent Transporters  
 Two component TBDTs are composed of the beta-barrel transmembrane channel and a 
surface exposed companion lipoprotein. Gonococcal iron acquisition from transferrin, 
lactoferrin, and hemoglobin involve two component TonB-dependent transporters, depicted in 
Figure 2. 
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Figure 2. Two component TonB-dependent transporters. The figure depicts the 3 iron 
acquisition systems that are composed of two component TonB-dependent transporters. These 
systems are responsible for iron acquisition from transferrin, lactoferrin, and hemoglobin. The 
outer membrane transporters are shown as cylinders that span the outer membrane (OM). The 
companion lipoproteins are shown tethered to the outer membrane, adjacent to their 
respective transporters. The TonB, ExB, and ExD complex (purple) is depicted as imbedded 
within the cytoplasmic membrane (CM), with TonB spanning the periplasm. The periplasmic 
binding protein, FbpA, is shown in yellow. The arrows pointing from the transmembrane 
channels to the periplasmic binding protein shown the path of the iron as it is transported. 
Lastly, the cytoplasmic membrane permease FbpB, and its associated ATPase FbpC, are 
shown in red within the cytoplasmic membrane. The hemoglobin receptors utilizes the TonB, 
ExbB, and ExbD complex, but a periplasmic binding protein or an ABC transporter has not 
been identified for the system. 
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Figure 2. Two component TonB-dependent transporters. 
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1. Transferrin Iron Acquisition 
 Transferrin iron acquisition by the gonococcus has been studied intensely and much is 
known about the process. The system contains two outer membrane proteins known as 
transferrin binding protein A (TbpA) and transferrin binding protein B (TbpB). All gonococcal 
strains studied to date have both tbpA and tbpB genes. The tbpA and tbpB genes have been 
shown to be expressed during natural mucosal infection with N. gonorrhoeae (1).  A gonococcal 
transferrin receptor mutant was unable to establish infection in human male volunteers, making 
the transferrin receptor both a nutrient acquisition system and an essential virulence factor (26). 
The immunogenicity of the transferrin binding proteins during natural infection has been 
examined, and although antibodies to recombinant TbpA and TbpB were detected, the levels 
were not significantly different from the control population (76). This indicates that despite the 
fact that the transferrin binding proteins are surface exposed, well conserved, and needed for 
successful infection, their immunogenicity would need to be boosted in order to serve as an 
effective vaccine candidate.  
  TbpA is a classical TBDT, composed of a transmembrane beta-barrel and a globular 
plug domain. TbpA contains 11 surface exposed loops, and loops 4 and 5 were shown to be 
critical for transferrin binding (12). TbpB is a surface tethered lipoprotein that contains two 
distinct domains. TbpB is completely surface exposed and contains two transferrin-binding-
competent lobes (28). E. coli expressing recombinant TbpA were able to specifically bind human 
transferrin (23). Mutants unable to express TbpA are incapable of internalizing iron from 
transferrin (24), however mutants unable to express TbpB were still able to internalize iron from 
transferrin at approximately 50% wild-type levels (4). Based on this information, it is understood 
that while TbpA expression is essential for iron acquisition from transferrin, the presence of 
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TbpB makes the process more efficient (25). The current model for iron uptake from transferrin 
is as follows: first, ferrated transferrin binds to TbpA and TbpB. TbpA and TbpB then extract the 
iron from transferrin, and the iron then interacts with the plug domain of TbpA for transport. 
TonB then initiates transport by pulling on the plug domain. Following transport, iron is released 
from the plug and subsequently captured by the periplasmic binding protein FbpA. FbpA 
resembles a single lobe of transferrin. Apo-FbpA has been shown to bind specifically and 
directly to TbpA (80). This interaction allows for apo-FbpA to be in the correct place and ready 
to receive iron from TbpA efficiently. After the transfer of iron, ferrated FbpA loses its affinity 
for TbpA and is allowed to pass through the periplasm. Holo-FbpA then associates with FbpB, a 
cytoplasmic permease. FbpB then accomplishes transport of the iron into the cytoplasm, using 
energy derived from FbpC, an ATPase (25).  
2. Lactoferrin Iron Acquisition 
 Less is known about lactoferrin iron acquisition, although the process is thought to be 
similar to transferrin iron acquisition. Lactoferrin iron acquisition is accomplished by LbpA and 
LbpB. Similarly to TbpA and TbpB, LbpA is a TBDT and LbpB is a surface tethered lipoprotein. 
LbpA is required for human lactoferrin utilization, but LbpB is not (8). Roughly 50% of 
gonococcal isolates contain an identical deletion of the lbpB gene and a portion of lbpA gene, 
leaving them unable to express the Lbps (2). In addition, if the genes are present, lbpB is subject 
to phase variation. While all isolates containing the lbpA and lbpB genes express LbpA, 70% do 
not express LbpB (2).  
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3. Hemoglobin Iron Acquisition 
 The hemoglobin uptake system is composed of HpuA and HpuB. HpuB is the TBDT 
spanning the outer membrane, and HpuA is the surface tethered lipoprotein. HpuA is roughly 
half the size of the other lipoproteins involved in two component TonB-dependent transport. 
Both proteins are absolutely required for iron acquisition from hemoglobin (20). Expression of 
hemoglobin utilization system is phase variable due to slipped-strand mispairing, caused by 
frameshifting that results from variable-length poly G tract in the hpuA gene (20).  Most lab 
strains are in the hemoglobin receptor “off” phase (21).  However, the hemoglobin receptor is 
often found in the “on” phase in women during the first half of the menstrual cycle (3). 
Hemoglobin binding to HpuA/B is not species specific, unlike the transferrin and lactoferrin 
binding proteins.  
C. Single Component TonB- Dependent Transporters 
 Single component TBDTs are composed of the beta-barrel transmembrane channel but do 
not utilize a surface exposed companion lipoprotein. Gonococcal iron acquisition from 
siderophores involves single component TonB-dependent transporters, depicted in Figure 3. The 
other TBDTs are largely uncharacterized and were identified via bioinformatics. 
1. Enterobactin Iron Acquisition 
 Enterobactin iron acquisition is accomplished by the single component TBDT known as 
ferric enterobactin transporter (FetA). Expression of FetA is iron repressed and subject to phase 
variation. Enterobactin is produced by various bacteria, including E. coli, Klebsiella species, and 
Salmonella species (68, 73, 74). Enterobactin is a catecholate-type siderophore. The fetA gene is 
upstream of genes that putatively encode a periplasmic binding protein, FetB, and an ABC  
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Figure 3. Single component TonB-dependent transporters. The figure depicts the 5 TBDT 
systems that are composed of a single transmembrane channel. These systems are largely 
uncharacterized, although FetA is known to transport certain xenosiderophores. The outer 
membrane transporters are shown as cylinders that span the outer membrane (OM). The 
TonB, ExB, and ExD complex (purple) is depicted as imbedded within the cytoplasmic 
membrane (CM), with TonB spanning the periplasm. The periplasmic binding protein FetB 
(aqua) is involved in siderophore transport. The periplasmic binding protein FetB2 (pink) is 
encoded near TdfF. It is hypothesized that the Fet system utilizes the FetC/D/E/F ABC 
transport system (plum). 
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Figure 3. Single component TonB-dependent transporters.  
 
  
 19  
  
transport system, FetC/D/E/F (Figure 3). Mutants lacking FetB expression were deficient in the 
utilization of enterobactin (14). More recently, FetA was also shown to transport other 
catecholate siderophores including dimers and trimers of dihydroxybenzoylserine and 
salmochelin S2 (43).  
2. Uncharacterized Single Component Transporters 
 The rest of the single component TBDTs are mostly uncharacterized and were identified 
via bioinformatics based on their similarity to other TBDTs. They were named TonB-dependent 
function (Tdf) F, G, H and J. TdfF is a 78 kD iron regulated protein that has been shown to be 
important for intracellular survival (41), perhaps suggesting that TdfF plays a role in intracellular 
iron acquisition after invasion of the host cell. There is a gene for a putative periplasmic binding 
protein upstream of TdfF, and it has been named fetB2 based on its similarity to fetB. TdfF is 
only detected in N. gonorrhoeae grown in cell culture medium in the presence of serum (41).  
 TdfG is iron repressed and is very large at 136 kD. Expression of TdfG is only detected 
in 17% of gonococcal strains, despite the fact that all gonococcal genomes contain tdfG. This is 
because the tdfG genes fall into 2 clades, and the antibodies used to assess TdfG expression only 
recognized some of the TdfG proteins. Based on its sequence, TdfG is most similar to heme 
transporters (89). However, a mutant lacking TdfG was still able to utilize heme as a sole iron 
source. TdfH is also large at 104 kD and also has sequence similarity to heme transport systems 
(89). Again, TdfH mutants were able to grow on heme as a sole iron source. Based on this 
finding, it is unlikely that TdfH or TdfG transport free heme (89).  
 TdfJ is an 86 kD TBDT that is present in all Neisseriae. Again, TdfJ shares sequence 
similarity with heme and siderophore transporters. TdfJ has been shown to be iron induced (30). 
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The meningococcal homologue of TdfJ is known as ZnuD, and it has been demonstrated to 
facilitate zinc acquisition (83). ZnuD is regulated by zinc uptake regulator, Zur, and ferric uptake 
regulator, Fur (51). ZnuD has also been shown to bind heme when expressed in E. coli, however 
there is no defect in heme utilization in a meningococcal znuD mutant (51). The znuD mutant 
was however defective for survival within epithelial cells and in adherence to and invasion of 
epithelial cells (51). ZnuD has been proposed as a potential candidate for inclusion in a 
meningococcal group B vaccine (44). It is said to be a good candidate because it is expressed in 
almost all meningococcal group B strains tested, is expressed during infection, and antibodies 
against it were able to trigger complement mediated killing of meningococcal group B strains 
under conditions of zinc limitation. 
D. Regulation 
 Iron uptake is highly regulated in order to maintain an optimum concentration within the 
cell and avoid the toxic effects of excess iron. Ferric uptake regulator, or Fur, controls the 
transcription of iron acquisition genes and a broad range of other genes (30, 85). Under iron-
replete conditions dimerized Fur binds iron, and the conformational change that occurs allows it 
to bind a DNA sequence known as the Fur box. The gonococcal Fur binding sequence is two 
hexameric direct repeats composed of ATAAT followed by ATTAT (45). When Fur is bound to 
the DNA, transcription is inhibited and genes are repressed. Under iron-deplete conditions, no 
iron is bound to Fur, and the protein is therefore unable to bind the Fur box and inhibit 
transcription (87).  
 Another form of regulation occurs via the two component regulatory system known as 
MisR/MisS. The MisR/MisS system is analogous to the PhoP/PhoQ system in Salmonella 
enterica. The systems are composed of a response regulator and an environmental sensor kinase. 
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In the case of S. enterica, PhoP is the response regulator and PhoQ is the sensor kinase (39). In 
the case of N. gonorrhoeae, MisR is the response regulator and MisS is the sensor kinase that is 
imbedded in the cytoplasmic membrane. The PhoP/PhoQ system directs virulence, regulates 
cellular activities, and mediates the adaption to Mg2+ limiting environments within S. enterica 
(39). Little is known about the gonococcal MisR/MisS system, except that it responds to 
antimicrobial peptides like LL-37. This indicates that MisR/MisS may play a role in responding 
to the host environment.  
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III. Research Objectives  
 In order to further investigate the structure, function, regulation, and expression of certain 
TonB-dependent transporters in N. gonorrhoeae, three goals were established for this study: 
1. Examine the role of two highly conserved regions of TbpB in lipidation.  
 It was hypothesized that mutation of the LSAC motif would prevent lipidation of TbpB. 
This hypothesis was addressed by examining expression and lipidation of TbpB in two mutants: 
MCV839 (TbpB LSAC) and MCV43 (TbpB ΔGly).  
2. Determine whether MisR/MisS regulates expression of TbpA and TbpB.  
 It was hypothesized that the MisR/MisS system played a role in iron-dependent 
regulation of TbpA and TbpB. This hypothesis was addressed by examining protein and RNA 
expression of TbpA and TbpB in three strains: FA19 (wild type), misR, and misRc. 
3. Assess the ability of recombinant TdfJ to bind hemin when expressed in E. coli. 
 It was hypothesized that TdfJ would bind hemin when expressed in E. coli. It was also 
hypothesized that TdfJ overexpressed in its native organism would bind hemin. These 
hypotheses were addressed by performing hemin sedimentation assays with E. coli strains 
expressing TdfJ and various other TBDTs, and performing hemin sedimentation assays with 
gonococci overexpressing TdfJ. Hemin binding was also assessed with hemin binding blots. 
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Materials and Methods 
 
I. Bacterial Strains and Growth Conditions 
 The N. gonorrhoeae and E. coli strains used throughout this study are listed in Table 1. 
Gonococcal strains were maintained on GC medium base (Difco) containing Kellogg’s 
supplement 1 (48) and 12 µM ferric nitrate at 37°C with the addition of 5% CO2. Before growth 
in liquid media, gonococcal strains were passed twice on GC agar. Liquid cultures of gonococcal 
strains used in the palmitate labeling experiments were grown in chemically defined media 
(CDM) in acid-washed glassware. The CDM was rendered iron free by treatment with Chelex 
100 (BioRad). Liquid cultures of gonococcal strains used in the MisR/MisS experiments were 
grown in gonococcal growth media (GCB) in acid-washed glassware. These strains were 
provided by the Shafer lab. Strains were grown in iron-replete and iron-deplete conditions for 2 
or 4 hours after doubling. Iron-replete conditions were accomplished by the addition of ferric 
nitrate at the beginning of growth and at doubling, and iron-deplete conditions were 
accomplished by the addition of desferrioxamine B (desferal) at doubling. 1mM IPTG was added 
to the MisR complement strain. All liquid cultures of gonococcal strains were grown at 37°C 
with the addition of 5% CO2 and shaking at 225 rpm. E. coli strains were cultured in Luria Broth 
(LB) containing 100 μg/ml carbenicillin, 50 μg/ml kanamycin, or 34 μg/ml chloramphenicol at 
37°C with shaking at 225 rpm. Expression strains were induced using 0.02% L-arabinose or 3 
mM IPTG added at an OD600 = 0.5. 
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Strain or Plasmid 
 
Description 
Source or 
Reference 
E. coli Strains 
BL21 (DE3) 
 
F- ompT hsdSB (rB-mB-) gal dcm (DE3) 
 
 
Novagen 
TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ 80lacZΔM15 ΔlacX74 
recA1 deoR araD139 Δ(ara-leu) 7697 galU galK rpsL 
(StrR) endA1 nupG  
Invitrogen 
Gonococcal Strains 
FA19 
 
Wild type 
 
Lab strain 
FA1090 Wild type Lab strain 
FA6905 
MCV407 
TbpBˉ (ΔtbpB) 
FA1090 ΔopaKEB tdfJˉ 
Lab strain 
Lab strain 
MCV411 FA1090 ΔopaKEB nspAc Lab strain 
MCV412 FA1090 ΔopaKEB tdfJc (with foreign RBS) Lab strain 
MCV839 TbpB LSAC (lbpB::Ω) (71) 
MCV843 TbpB ΔGly (lbpB::Ω) (71) 
misR  Shafer 
misRc  Shafer 
Plasmids 
pBAD-TOPO 
 
Ampr 
 
Invitrogen 
pUNCH412 BL21(DE3)pLysE containing pUNCH412 (23) 
pUNCH1313 pET30a containing tdfH (89) 
pUNCH1316 pET30a containing tdfG (89) 
pUNCH1321 pET30a containing tdfF (89) 
pVCU312 pBAD-TOPO with no insert This study 
pVCU313 pBAD-TOPO containing tdfJ SS1 This study 
pVCU314 pBAD-TOPO containing tdfJ SS2 This study 
Table 1. Strains and Plasmids used in this study. 
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II. Construction of Expression Plasmids 
 The full length tdfJ expression plasmid pVCU313 (Table 1) was constructed by first 
amplifying the tdfJ gene from wild-type gonococcal strain FA1090 genomic DNA. PCR was 
performed using Platinum PCR SuperMix High Fidelity (Invitrogen) and primers (Table 2) were 
synthesized by Integrated DNA Technologies. The forward primer, oVCU764 
(CCATGGCACGAGAAGCCAAAATGGCACAAATCACA), contained an NcoI site (bold) 
(Table 2) and amplified the tdfJ native signal sequence. The NcoI site was engineered onto the 5’ 
end of forward primer so that the N-terminal leader sequence provided by the pBAD-TOPO 
vector could be removed. The reverse primer, oVCU763 (TTAAAACTTCACGTTTACGCCGC 
CGGTAAAGCTG), encoded the terminal phenylalanine of tdfJ, thus excluding the V5 epitope 
and polyhistidine region provided by the pBAD-TOPO vector (Table 2). The pVCU313 
expression plasmid yielded what will be referred to as the start site 1 (SS1) expression strain.  A 
second tdfJ expression plasmid, pVCU314 (Table 2), was constructed in which the tdfJ gene was 
amplified from the second methionine, which is located 5 amino acids downstream of the first 
methionine in the protein sequence. This second expression plasmid was created because the true 
start site for tdfJ is unknown. The second forward primer, oVCU765 (CCATGGCACAAATCA 
CACTCAAACCCATTGTTTTA), also contained an NcoI site (bold) (Table 2). The pVCU314 
expression plasmid yielded what will be referred to as the start site 2 (SS2) expression strain.  
PCR products were then cloned directly into the pBAD-TOPO vector (Invitrogen) according to 
manufacturer’s instructions. Transformants were screened via restriction enzyme digest, 
followed by gel electrophoresis. The restriction enzymes used in screening and in the removal of 
the pBAD-TOPO leader sequence were obtained from New England Biolabs. During screening, 
expression plasmid pVCU312 (Table 1), containing the empty pBAD-TOPO vector with no 
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Oligonucleotide Amplicon Sequence (5’-3’) 
oVCU68 tbpA RT-PCR Fwd GGGGGTCACGAAAAGTGTAAAGCGA 
oVCU72 tbpA RT-PCR Rev CGACGCTTAGGGGAAACCGCTTCAG 
oVCU70 tbpB RT-PCR Fwd TAAACAGTCCGCCGTATTTGTGGTT 
oVCU73 tbpB RT-PCR Rev GTCGGGTAGCGTTGCTGAAGTTGTC 
oVCU763 full length tdfJ Reverse TTAAAACTTCACGTTTACGCCGCCGGTAAAGCTG 
oVCU764 full length Nco1-tdfJ Fwd SS1 CCATGGCACGAGAAGCCAAAATGGCACAAATCACA 
oVCU765 full length Nco1-tdfJ Rev SS2 CCATGGCACAAATCACACTCAAACCCATTGTTTTA 
Table 2. Oligonucleotides used in this study. 
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insert, was identified. After the restriction enzyme digest, transformants that resulted in bands 
corresponding to the correct size insert were then verified via DNA sequencing at the VCU 
Nucleic Acids Core. The resulting expression strains contained tdfJ from start site 1 and start site 
2, under control of the araBAD promoter (PBAD), which is tightly regulated by the product of the 
araC gene. L-arabinose forms a complex with AraC which allows transcription to begin.  
III. Recombinant Protein Expression 
 For induction of TdfJ expression from pVCU313 and pVCU314, overnight cultures of 
the E. coli were grown in LB containing 100 μg/ml carbenicillin at 37°C with shaking at 225 
rpm. For induction of TbpA expression from pUNCH412, overnight cultures of the E. coli were 
grown in LB containing 100 μg/ml carbenicillin at 37°C with shaking at 225 rpm. For induction 
of TdfF expression from pUNCH1321 and TdfG expression from pUNCH1316, overnight 
cultures of the E. coli were grown in LB containing 50 μg/ml kanamycin and 34 μg/ml 
chloramphenicol at 37°C with shaking at 225 rpm. For induction of TdfH expression from 
pUNCH1313, overnight cultures of the E. coli were grown in LB containing 50 μg/ml 
kanamycin at 37°C with shaking at 225 rpm. 100 μl of overnight culture was then used to 
inoculate 10 mL LB containing the appropriate antibiotics. Cultures were grown for 
approximately 2 hours until they reached an OD600=0.5. Once the appropriate density was 
achieved either L-arabinose (Sigma Aldrich) or isopropyl-β-D-1-thiogalactopyranoside (IPTG) 
was added to the cultures to induce protein expression. To induce TdfJ expression from start site 
1 and start site 2, L-arabinose was added to the cultures at a final concentration of 0.02%. The 
empty vector control was treated in the same manner. To induce TdfF, TdfG, and TdfH 
expression, 3 mM IPTG was added to the cultures. To induce TbpA expression, 1 mM ITPG was 
added to the cultures. For each strain an induced and uninduced condition was performed. No L-
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arabinose or IPTG was added to the uninduced cultures to serve as a negative control. The 
cultures were then allowed to grow for an additional 4 hours at 37°C with shaking at 225 rpm. 
Following the four hour growth, whole cell lysates were made by pelleting 1 mL of culture. The 
pellets were solubilized in 2x laemmli solubilizing buffer for subsequent SDS-PAGE analysis. 
IV. Whole Cell Dot Blots 
 Whole cell dot blots were performed in order to test for surface exposure of gonococcal 
proteins expressed within the various E. coli expression strains. E. coli cultures were grown as 
described above. First, nitrocellulose was wetted in LS-TBS and placed in the S&S Minifold I 
Dot Blot system (Whatman) on top of gel blot paper (Whatman). After a 4 hour induction, 
cultures were standardized to 10,000 Ku (Klett unit) and added to wells in duplicate or triplicate. 
The membrane was allowed to dry for one hour and it was removed and stored overnight. The 
membrane was blocked, probed, and developed in the same manner as a western blot. The empty 
vector control (pVCU312) was included on the dot blots and was probed with every protein 
specific antibody to ensure antibody specificity. 
 A) Detection of TbpA (using HRP-Tf) 
 In order to detect TbpA, nitrocellulose membranes were first blocked with HS-TBS 
containing 5% BSA for one hour with gentle shaking. The membrane was probed with primary 
HRP-Tf at a dilution of 1:10,000 for 1 hour. The membrane was washed 3 times for 10 minutes 
in HS-TBS containing 0.05% Tween 20. The membrane was developed using the Opti-4CN 
system (Biorad).   
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 B) Detection of TdfF, TdfG, and TdfH 
 In order to detect TdfF, TdfG, and TdfH, nitrocellulose membranes were first blocked 
with HS-TBS containing 5% BSA for one hour with gentle shaking. The membrane was probed 
with primary anti-TdfF, TdfG, and TdfH antibodies at a dilution of 1:5,000 for 1 hour. The 
membrane was washed 3 times for 10 minutes in HS-TBS. The primary antibody was detected 
with secondary goat anti-rabbit IgG-AP (Southern Biotech) at a dilution of 1:5,000 for 1 hour. 
The membrane was washed again, and then developed using the NBT/BCIP system. 
 D) Detection of TdfJ 
 TdfJ was detected using anti-TdfJ (guinea pig 117) as described below. 
V. Hemin Sedimentation Assays 
 Hemin sedimentation assays were performed in order to assess the ability of each 
gonococcal protein, expressed on the surface of E. coli, to bind hemin. For this experiment the 
following proteins were assessed: TbpA (pUNCH412), TdfF (pUNCH1321), TdfG 
(pUNCH1316), TdfH (pUNCH1313), TdfJ from SS1 (pVCU313), and TdfJ from SS2 
(pVCU314). The TdfF, TdfG, and TdfH expression strains were provided by the Sparling lab 
(89). The TbpA expression strain was created by Dr. Cornelissen (23). The strain containing the 
empty vector (pVCU312) served as the negative control. Cultures were grown and protein 
expression was induced for four hours. After the four hour induction, 1 mL of culture was 
removed in order to prepare whole cell lysates for subsequent SDS-PAGE analysis. The 
remainder of the culture was moved to a 14 mL conical tube and was centrifuged at 3,000 rpm 
for 15 minutes. The supernatant was removed and the pellet was resuspended in 1 mL sterile 
PBS containing 5% dimethyl sulfoxide (DMSO). The DMSO was included in order to prevent 
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non-specific hemin binding. The cells were centrifuged at 3,000 rpm for 15 minutes. The 
supernatant was removed and the pellet was again resuspended in 1 mL sterile PBS containing 
5% DMSO. The cultures were standardized to and OD600=1. Hemin (Sigma Aldrich), dissolved 
in 0.1 N sodium hydroxide (NaOH) and PBS containing 5% DMSO at a concentration of 15 µM 
and 20 µM, was added to the appropriate wells of a v-bottom 96-well plate. 150 µl of the 
standardized cultures was added to the appropriate wells containing hemin. Each condition was 
performed in quadruplicate for both induced and uninduced conditions and in the presence of: no 
hemin, 15 µM hemin, or 20 µM hemin. Wells containing only hemin and PBS containing 5% 
DMSO at 15 µM and 20 µM (no cells) served as the 100% saturated, or 100% unbound, control. 
These wells were used as the “100% unbound” control because they represent the condition in 
which no hemin binds the cells, leaving all of the hemin unbound. The plate was allowed to 
incubate at room temperature for one hour with gentle rocking. After incubation, the plate was 
centrifuged at 3,000 rpm for 15 minutes in order to pellet the cells and any hemin that they 
precipitated. 100 µl of the supernatant in each well was transferred to a flat-bottom 96-well plate 
and the OD405 of each sample was read with a plate reader. The OD405 of each well was 
compared to the corresponding 100% saturated control well and the percent hemin bound was 
calculated. This was done by multiplying the OD405 value by 100 and then dividing the product 
by the OD405 value of the 100% saturated control well. This resulted in the percent hemin 
unbound, indicating the amount of hemin remaining in the supernatant that did not bind to the 
cells. This value was then subtracted from 100, yielding the percent hemin bound for each 
condition. This assay was also done with gonococcal strains in order to assess TdfJ's ability to 
bind hemin in its native organism. MCV407, the tdfJ knockout, and MCV412, the tdfJ 
complement strain which overexpresses TdfJ, were grown in GCB for 5 hours in the shaker 
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incubator at 37°C with shaking at 225 rpm with the addition of 5% CO2 in acid-washed flasks. 
MCV411, the nspA complement strain, was used as a negative control. IPTG was added to the 
induced complement strain flasks at the beginning of growth. Uninduced MCV412 was also 
cultured. After growth, the assay was performed in the way described above with one exception. 
During the one hour incubation step during which the hemin is allowed to bind to the cells, the 
96-well plate was kept in the shaker incubator at 37°C with gentle shaking and the addition of 
5% CO2. Protocol for hemin sedimentation assay was adapted from the one used to assess heme 
binding ability of meningococcal ZnuD (51). 
VI. Multiple Sequence Alignment 
 TdfJ, FetA, and TbpA were aligned with other representative heme receptors using 
ClustalW, a multiple sequence alignment program (52).  The slow/accurate setting was used to 
align the given protein sequences. For the pairwise alignment parameters, the gap open penalty 
was reduced to 5. For the multiple alignment parameters, the gap open penalty was reduced to 5. 
The multiple sequence alignment was then uploaded to Jalview (95), and the presence of the 
FRAP motif, the conserved histidine, and the NPNL motif was assessed.  
VII. Ribonuclease Leakage Assays 
 Ribonuclease (RNase) leakage assays were performed in order to see which E. coli 
expression strains had leaky outer membranes. It has previously been shown that the TbpA E. 
coli expression strain (pUNCH412) leaks RNase. The E. coli strains used in the assay were 
grown on LB agar plates containing the appropriate antibiotics (without RNA) overnight at 
37°C. LB agar plates containing carbenicillin, kanamycin, or kanamycin and chloramphenicol 
were made that also contained RNA. Type VI ribonucleic acid from torula yeast (Sigma) was 
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added to the media at a final concentration of 1.5%. The media, antibiotic, and RNA mixture was 
brought to a pH of 7.0 with 10 N NaOH before adding the agar, autoclaving, and pouring the 
plates. After the plates cooled, either L-arabinose or IPTG was spread on top of the plates to 
induce protein expression. A final concentration of 0.02% L-arabinose was spread onto plates 
containing RNA and carbenicllin in order to induce expression of TdfJ from SS1 and SS2. A 
final concentration of 3mM IPTG was spread onto plates containing RNA and carbenicillin, 
kanamycin, or kanamycin and chloramphenicol to induce TbpA, TdfF, TdfH, and TdfG 
expression. The strains were re-streaked onto these plates and grown overnight at 37°C. The 
following day, the plates were gently flooded with 0.1 N HCl and photographed. The E. coli 
strain expressing the empty vector was used as a negative control and the E. coli strain 
expressing TbpA was used as a positive control. If the bacteria were leaking RNase, the addition 
of HCl would cause a dark halo around the bacterial growth. If the bacteria were not leaking 
RNase, the agar would remain opaque and off-white in color.  
VIII. Palmitate Labeling of Lipidated Proteins 
 In order to assess the importance of the LSAC motif to the lipidation of TbpB, the Click-
iT labeling system (Invitrogen) was employed. The following strains were used for this 
experiment: FA19 (wild type), FA6905 (TbpBˉ), MCV839 (TbpB LSAC), and MCV843 (TbpB 
ΔGly). FA6905 does not produce TbpB, and therefore served as a negative control. In MCV839, 
the LSAC sequence was mutated to an LAAA. In MCV843, a conserved stretch of four glycine 
residues downstream of the LSAC sequence was deleted. The strains were grown in CDM as 
described above. After doubling, azide-labeled palmitic acid (Invitrogen) was added to a final 
concentration of 50µM. Cultures were then allowed to grow for an additional 4 hours.  Bacteria 
were then centrifuged, washed twice with sterile PBS, and resuspended in lysis buffer (50 mM 
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Tris [pH 8.0], 0.1% SDS). Benzonase nuclease was added and the bacteria were allowed to 
incubate for 1 hour at 4° to ensure complete lysis. Samples were centrifuged at a low speed in 
order to get rid of intact bacteria and cellular debris. The lysate was transferred to a clean tube 
and solubilized proteins were coupled to biotin alkyne according to the manufacturer’s 
instructions. Samples were resuspended in Laemmli solubilizing buffer and stored at -20°C. 
Samples were heated at 100°C for 2 minutes and loaded onto a 7.5% polyacrylamide gel 
(without the addition of β-mercaptoethanol). After electrophoresis, the proteins were transferred 
to nitrocellulose and stained as detailed below. The same blot was then probed with avidin-HRP 
(Biorad) to detect palmitoylated proteins, and then again with anti-TbpB antibody to detect full 
length TbpB, as described below.  
IX. Detection of Lipidated Proteins 
 In order to detect lipidated proteins, nitrocellulose membranes were first blocked with 
high salt Tris-buffered saline (HS-TBS) (20mM Tris base, 500mM NaCl) containing 1% bovine 
serum albumin (BSA) for one hour with gentle shaking. The membrane was then probed with 
avidin-HRP (Biorad) at a dilution of 1:2,000 for 1 hour. The blot was washed 3 times for 10 
minutes in HS-TBS containing 0.05% Tween 20, and developed using enhanced 
chemiluminescence (ECL) (Pierce) according to the manufacturer’s instructions. Bands were 
visualized by exposing X-ray film to the blots after the addition of the ECL reagents. The same 
blot was then re-blocked and probed for full length TbpB as detailed below. 
X. Western Analysis 
 Samples of N. gonorrhoeae or E. coli were grown as described above. For the 
MisR/MisS experiments, gonococcal cultures were grown under iron-deplete and iron-replete 
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conditions, standardized to cell density, and pelleted. For analysis of protein expression within 
the E. coli expression strains used in the hemin sedimentation assays, cultures were induced for 
four hours and 1 mL was removed and centrifuged at 14,000 rpm for 1 minute. All cell pellets 
were resuspended in 100 µl 2X laemmli solubilizing buffer and stored at -20°C. When needed, 1 
µl of benzonase buclease (Sigma) was added to whole cell lysates in order to reduce viscosity. 
Whole cell lysates were incubated with the benzonase at room temperature for 30 minutes. 
Before loading, 5% β-mercaptoethanol (Sigma) was added and samples were heated at 95°C for 
2 minutes. Proteins were then analyzed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE). Proteins were separated on 7.5% polyacrylamide gels using a 
Mini-Protean III apparatus (Biorad). Separated proteins were subsequently transferred to a 
nitrocellulose membrane (86) in 20mM Tris base, 150mM glycine and 20% methanol in a 
submerged transfer apparatus (Biorad) for 16 hours at a constant current of 28mA. After the 
transfer, membranes were washed quickly with deionized water and then stained with Ponceau S 
solution (0.1% w/v Ponceau S, 5% acetic acid) for roughly 10 minutes to ensure equal loading. 
Excess dye was removed with deionized water and the stained gels were scanned. 
 A) Detection of TbpA (with anti-TbpA antibody, Rabbit 11581) 
 In order to detect TbpA, nitrocellulose membranes were first blocked with HS-TBS 
containing 5% BSA for one hour with gentle shaking. The membrane was probed with primary 
anti-TbpA antibodies at a dilution of 1:1,000 for 1 hour. The membrane was washed 3 times for 
10 minutes in HS-TBS containing 0.05% Tween 20. The primary antibody was detected with 
secondary goat anti-rabbit IgG-AP (goat anti-rabbit IgG conjugated to alkaline phosphatase) 
(Southern Biotech) at a dilution of 1:5,000 for 1 hour. The membrane was washed again, and 
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developed using the nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolylphosphate 
(BCIP) development system (Sigma). 
 B) Detection of TbpB (with anti-TbpB antibody, Rabbit 162-3) 
 In order to detect TbpB, nitrocellulose membranes were first blocked with low salt Tris-
buffered saline (LS-TBS) (50 mM Tris, 150 mM NaCl) containing 5% non-fat skim milk 
(Sigma) for one hour with gentle shaking. The membrane was probed with primary anti-TbpB 
antibodies at a dilution of 1:5,000 for 1 hour. The membrane was washed 3 times for 10 minutes 
in LS-TBS containing 0.05% Tween 20. The primary antibody was detected with secondary goat 
anti-rabbit IgG-AP (Southern Biotech) at a dilution of 1:3,000 (for palmitate labeling 
experiment) or 1:5,000 (for the MisR/MisS experiments) for 1 hour. The membrane was washed 
again, and developed using the NBT/BCIP system. 
 C) Detection of TdfJ (with anti-TdfJ antibody, Guinea Pigs 116, 117, 118, and 119) 
 In order to detect TdfJ, nitrocellulose membranes were first blocked with low salt Tris-
buffered saline (LS-TBS) containing 5% non-fat skim milk (Sigma) for one hour with gentle 
shaking. The membrane was probed with primary anti-TdfJ antibody at 1:200 (guinea pigs 116 
and 117), or at 1:100 (guinea pigs 118 and 119) for one hour. Once anti-TdfJ antibodies were 
characterized antibody 117 was used at 1:200 dilution for the remaining experiments. The 
membrane was washed 3 times for 10 minutes in LS-TBS containing 0.05% Tween 20. The 
primary antibody was detected with secondary rabbit anti-guinea pig IgG-AP (Thermo 
Scientific) at a dilution of 1:3,000 for 1 hour. The membrane was washed again, and developed 
using the NBT/BCIP system.  
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 Alternatively, the primary anti-TdfJ antibody was detected with goat anti-guinea pig IgG-
HRP (Southern Biotech) and developed using ECL (Pierce) according to the manufacturer’s 
instructions. Bands were visualized by exposing autoradiographic film to the blots after the 
addition of the ECL reagents.  
XI. Coomassie Blue Protein Staining 
 Following electrophoresis, SDS-PAGE gels were stained with Coomassie blue (0.25% 
Coomassie R-250, 50% methanol, 10% glacial acetic acid) overnight at room temperature. The 
following day the gels were then destained in 20% methanol and 5% glacial acetic acid at room 
temperature with gentle shaking for 3-6 hours until background staining was diminished. 
XII. Hemin Binding Blots 
 Hemin binding blots were performed in order to identify hemin-binding gonococcal 
proteins. FA1090 sarkosyl insoluble outer membrane preparations (OMP), provided by a fellow 
lab member, were used for the hemin binding blots. The FA1090 outer membrane preparations 
were made from cultures grown in iron-replete and iron-deplete conditions. The proteins were 
separated on 7.5% and 15% polyacrylamide gels by subjecting them to electrophoresis. 
Duplicate gels were made for both the 7.5% and 15% gels. After electrophoresis, one of each of 
percentage gel was transferred onto nitrocellulose according to the method described above. The 
remaining gels were stained with Coomassie blue as detailed above. The gels that were 
transferred onto nitrocellulose were subsequently rinsed with TBS containing Tween 20 (10 mM 
pH 8.0 Tris-HCl containing 150 mM NaCl and 0.1% Tween 20) 3 times for 10 minutes. The 
blots were probed with TBS containing 10-6 M hemin (Sigma Aldrich) for 1.5 hours at room 
temperature with gentle shaking. The blots were washed 3 times for 10 minutes. Bound hemin 
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was visualized via its inherent peroxidase activity using ECL. The blots were exposed to 
autoradiographic film for approximately 20 seconds. Bands on the Coomassie stained gels that 
corresponded to hemin binding bands on the film were excised and sent for protein identification 
at the VCU Mass Spectrometry Core.  
XIII. RNA Isolation 
 Gonococcal cultures were grown in GCB in iron-replete and iron-deplete conditions as 
detailed above. At 2 hours and 4 hours after doubling, 5 mL of culture was mixed with 10 mL 
RNAprotect (Qiagen), vortexed for 5 seconds, and incubated at room temperature for 5 minutes. 
The culture was centrifuged for 15 minutes at 3,000 rpm. The supernatant was decanted and the 
pellets were stored at -20°C. Total RNA was isolated using the RNeasy Mini Kit according to 
manufacturer’s instructions (Qiagen). Purified RNA was cleaned up and treated with RNase-free 
DNase twice as directed by the manufacturer. Lastly, 1 µl of Superase-In (Ambion) was added 
prior to storage at -80°C. 
XIV. Qualitative Reverse Transcriptase PCR 
 RNA isolated from FA19 (wild type), misR (MisRˉ), and misRc (complement) strains 
grown under iron-replete and iron-deplete conditions was reverse transcribed using the 
ThermoScript RT-PCR system (Invitrogen). In order to create the cDNA, random hexamers, 
RNA, and dNTPs were mixed and incubated at 70°C for 10 minutes in order to denature the 
RNA. The cDNA synthesis mix was made according to manufacturer’s instructions and added to 
each reaction tube while on ice. The mixture was incubated at 25°C for 10 minutes, followed by 
a 1 hour incubation at 60°C. The reaction was terminated by incubating the reaction tubes at 
85°C for 5 minutes. Finally, 1 µl of RNase H was added and the tubes were incubated at 37°C 
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for 20 minutes. In order to rule out DNA contamination, parallel reactions were carried out in the 
absence of reverse transcriptase. 
 Using the resultant cDNA, portions of TbpA and TbpB were amplified from each 
condition using Platinum Taq DNA Polymerase (Invitrogen) according to the manufacturer’s 
instructions. The primers used for PCR amplification are located in Table 2. . In order to amplify 
part of TbpA, oVCU68 (GGGGGTCACGAAAAGTGTAAAGCGA) and oVCU72 
(GGGGGTCACGAAAAGTGTAAAGCGA) were used. In order to amplify part of TbpB, 
oVCU70 (CGACGCTTAGGGGAAACCGCTTCAG) and oVCU73 
(GTCGGGTAGCGTTGCTGAAGTTGTC) were used. TbpA and TbpB were also amplified 
from FA19 chromosomal DNA using the same primers for size comparison. After the initial 
denaturation step at 95°C for 5 minutes, DNA was amplified for a total of 30 cycles. Each cycle 
began with 1 min at 94°C to denature, followed by 30 seconds at 59°C to anneal, and 1 minute 
and 20 seconds at 72°C to extend the DNA. Lastly, there was a final extension step of 10 
minutes at 72°C. Amplicons were detected by ethidium bromide staining of 2.5% agarose gels.  
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Results  
 
 
 
I. Role of LSAC Motif in the Lipidation of TbpB 
 As mentioned previously, TbpB is the surface tethered lipoprotein that works in 
conjunction with TbpA, a TBDT, to transport iron from human transferrin. TbpA expression is 
essential for iron acquisition from transferrin, however the presence of TbpB is not required but 
makes the process more efficient. The tbpB gene is present in all gonococcal isolates 
characterized to date, and has been shown to be expressed during infection (1). Due to its 
potential as a vaccine candidate, further study into the presentation of TbpB on the gonococcal 
cell surface is warranted.   
 In order to learn more about the presentation of the TbpB protein on the bacterial surface, 
the role of two highly conserved regions within TbpB were assessed. The first conserved region 
of interest was the LSAC motif. This motif is representative of the classical lipobox, and is 
located at the amino terminus of TbpB. This motif consists of four residues, and it is the 
recognition site for signal II peptidase. The cysteine residue within the LSAC sequence serves as 
the first amino acid in the mature protein after cleavage. It was hypothesized that this cysteine is 
also the site of lipidation, which anchors TbpB to the outer membrane. TbpB was previously 
demonstrated to be lipidated (4), but the role of the LSAC motif in this process has not yet been 
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elucidated. Lipidation is the covalent modification of a protein with a variety of lipids. Many 
outer membrane proteins undergo lipidation, and these lipid modifications play important roles 
in protein function and localization (64). The second conserved region, consisting of four glycine 
residues in tandem, is two amino acid residues downstream of the LSAC motif.  
A. LSAC Motif is Necessary for the Lipidation of TbpB 
 In order to assess the roles of these two conserved regions on the lipidation of TbpB, two 
mutant strains were tested: MCV839 and MCV843 (Table 1). MCV839 has the LSAC sequence 
mutated to LAAA. MCV843 contains a deletion of the four conserved glycines. FA19 was used 
as the wild type control, while FA6905 was used as the negative control because it is unable to 
express TbpB. These four strains were grown under iron-depleted conditions in chemically 
defined media in the presence of azide labeled palmitic acid. Biotin alkyne was then conjugated 
to the proteins containing the palmitic acid. Whole cell lysates of the cultures were prepared and 
subjected to SDS-PAGE, and subsequently transferred to nitrocellose. Palmitoylated proteins 
were then detected using avidin-HRP and developed using ECL (Figure 4A). TbpB was lipidated 
in FA19 (wild type) and in MCV843 (TbpB ΔGly mutant), but not in MCV839 (TbpB LSAC 
mutant). There is a lipidated protein slightly larger than TbpB which is apparent in all lanes; 
however, the black arrow denotes the band of interest whose size corresponds to the size of 
TbpB. The same blot was also probed with anti-TbpB antibodies and developed using the 
NBT/BCIP system (Figure 4B). Full length TbpB was detected in FA19, MCV839, and 
MCV843, but not in FA6905 (TbpBˉ). Based on these results, we concluded that although full 
length TbpB was produced by MCV839, it was not lipidated. On the other hand, lipidated, full 
length TbpB was expressed in MCV843. Therefore, the LSAC mutation had an effect on TbpB 
lipidation and the glycine deletion did not. 
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Figure 4. TbpB produced by MCV839 is not lipidated. (A) Wild type, tbpBˉ , LSAC 
mutant, and glycine deletion mutant were grown under iron-depleted conditions in the 
presence of azide-labeled palmitic acid. Biotin alkyne was then conjugated to any proteins 
containing the palmitic acid. Whole cell lysates were prepared and subjected to SDS-PAGE. 
Following transfer to nitrocellulose, proteins containing biotin-azide labeled palmitic acid 
were detected using avidin-HRP and developed with ECL. (B) Full length TbpB was detected 
on the same blot using anti-TbpB antibody 162-4 and developed using the NBT/BCIP system. 
Approximate positions of molecular mass markers are shown on the right. 
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Figure 4. TbpB produced by MCV839 is not lipidated.  
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II. Regulation of the Transferrin Binding Proteins by MisR/MisS 
 The transferrin binding proteins, TbpA and TbpB, are critical to the uptake of iron from 
human transferrin. Since they are involved in the uptake of iron, they are heavily regulated in 
order to maintain an optimal intracellular iron concentration. Expression of both proteins is 
repressed under iron-replete conditions (24). The system is also regulated by Fur, and the Fur 
box lies upstream of the TbpB start site.  
 RNA-Seq studies performed by the Shafer lab indicated that tbpA and tbpB, among many 
other genes, were effected by MisR expression. The Shafer lab also showed that MisR was able 
to bind upstream of the tbpBA operon via DNA footprinting. Based on these preliminary results 
it was hypothesized that gonococcal MisR/MisS may also play a role in regulating TbpA and 
TbpB.  
 MisR/MisS is analogous to the PhoP/PhoQ system in Salmonella. The PhoP/PhoQ 
system responds to various antimicrobial peptides (79), and this seems to hold true for the 
MisR/MisS system in N. gonorrhoeae, as it has been shown to respond the antimicrobial peptide 
LL-37. The MisR/MisS system regulates and influences numerous biological functions within N. 
meningitidis. Genes regulated by MisR/MisS in N. meningitidis are necessary for transcriptional 
regulation, iron assimilation, metabolism, type I protein transport, and protein folding (91). 
MisR/MisS also influences the immunotype and inner core structure of LOS in the 
meningococcus (90). Of the TBDTs expressed by N. meningitidis, only tdfH and hmbR are 
affected by MisR/MisS (91). HmbR is the meningococcus-specific hemoglobin outer membrane 
receptor (82).  
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A. Protein Expression of TbpA and TbpB is regulated by MisR/MisS 
 In order to examine the effect that MisR has on expression of TbpA and TbpB, protein 
expression in the following strains was examined via western blot: FA19 (wild type), misR 
(MisRˉ), and misRc (MisR complement). The strains were grown in GCB under iron-replete and 
iron-depleted conditions for two or four hours after doubling. In order to achieve iron-replete 
conditions, ferric nitrate was added to the media at the beginning of growth and at doubling. In 
order to achieve iron-deplete conditions, no ferric nitrate was added to the media, and desferal 
was added at doubling. 1mM IPTG was added to the misRc strain at the beginning of growth in 
order to induce the expression of ectopically provided misR. Whole cell lysates were made from 
the cultures at 2 hours and 4 hours post doubling. The whole cell lysates were then subjected to 
SDS-PAGE and the separated proteins were subsequently transferred onto nitrocellulose 
membranes. The membranes were then probed for TbpA or TbpB using protein specific 
antibodies and developed using the NBT/BCIP system.  
 At 2 hours post doubling, expression of TbpA looks roughly equivalent across all strains 
under iron-deplete conditions. However, expression of TbpA in the misR strain is much greater 
than in the wild type or complement strains in iron-replete conditions (Figure 5A). This indicates 
that MisR down-regulates expression of TbpA under iron-replete conditions, and this effect is 
lost when MisR is not present. At 4 hours post doubling, the same trend is not seen (Figure 5B). 
At this time point it appears that expression of TbpA in the wild type strain is greater than 
expression of TbpA in both the misR and misRc strain under both iron-deplete and iron-replete 
conditions. It is also apparent at both time points that the expression of TbpA in misRc strain does 
not appear to fully complement wild type expression levels. Expression levels in misRc strain  
  
 45  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5. MisR regulated TbpA protein expression. Strains were grown for 2 hours (A) 
and 4 hours (B) after doubling in iron-replete and iron-depleted conditions. Standardized 
whole cell lysates were made and subjected to SDS-PAGE. After transfer to nitrocellulose, 
the blots were probed with anti-TbpA antibody 11581 in order to examine the effects on 
TbpA expression. The arrows on the right side indicate the band of TbpA expression. 
Molecular mass markers are shown on the left. The non-specific band detected at 
approximately 45 kD is used to show equivalent loading.  
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Figure 5. MisR regulated TbpA protein expression. 
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 appear to fall somewhere between the wild type strain and the mutant strain. One possible 
explanation for this phenomena is that insertionally inactivating MisR results in decreased MisS 
expression. It is not a polar mutation, but is likely causing differences in protein expression 
between wild type and complement. Another possible explanation for this phenomena is that 
differences in expression are caused by the fact that misR is ectopically provided in the 
complement strain. The ectopically provided misR has an IPTG inducible promoter, and is 
therefore expressed in a different way than in the wild type strain.  
 At 2 hours post doubling, TbpB expression also looks roughly equivalent across all 
strains under iron-depleted conditions. However, expression of TbpB in the misR strain is greater 
than in the wild type or complement strains in iron-replete conditions (Figure 6A). This indicates 
that MisR is also down-regulating the expression of TbpB under iron-replete conditions, and this 
effect is lost when MisR is not present. At 4 hours post doubling, the trend is mostly lost (Figure 
6B). However, expression of TbpB in the misR strain under iron-replete conditions looks to be 
slightly greater than TbpB expression in the wild type or complement strains under iron-replete 
conditions. Interestingly, there is a marked increase in the detection of TbpB breakdown 
products in the misR strain under iron-deplete conditions, despite the fact that expression of full 
length TbpB looks approximately equivalent across all strains (Figure 6B). Again, the misRc 
strain does not appear to fully complement wild type levels of TbpB expression. 
B. tbpA and tbpB transcripts are regulated by MisR/MisS 
 In order to examine the affect that MisR has on the expression of TbpA and TbpB, 
transcripts from the following strains were detected via RT-PCR: FA19 (wild type), misR 
(MisRˉ), and misRc (MisR complement). The strains were grown in GCB under iron-replete and 
iron-depleted conditions for four hours after doubling. In order to achieve iron-replete  
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Figure 6. MisR regulated TbpB protein expression. Strains were grown for 2 hours (A) 
and 4 hours (B) after doubling in iron-replete and iron-depleted conditions. Standardized 
whole cell lysates were made and subjected to SDS-PAGE. After transfer to nitrocellulose, 
the blots were probed with anti-TbpB antibody 162-4 in order to examine the effects on TbpB 
expression. The arrows on the right side indicate the band of TbpB expression. A section of 
the ponceau stain is included below the blot to show even loading. Molecular mass markers 
are shown on the left. 
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Figure 6. MisR regulated TbpB protein expression. 
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conditions, ferric nitrate was added to the media at the beginning of growth and at doubling. In 
order to achieve iron-deplete conditions, no ferric nitrate was added to the media, and desferal 
was added at doubling. 1mM IPTG was added to the misRc strain at the beginning of growth in 
order to induce the expression of ectopically provided misR. At 2 hours and 4 hours post 
doubling, culture was removed, treated with RNAprotect (Qiagen), pelleted, and stored before 
total RNA was isolated using the RNeasy Mini Kit (Qiagen). Total RNA from each strain was 
reverse transcribed using the ThermoScript RT-PCR system (Invitrogen). Using the resultant 
cDNA, portions of TbpA and TbpB were amplified from each condition using Platinum Taq 
DNA Polymerase (Invitrogen). Amplicons were then detected using ethidium bromide staining 
of 2.5% agarose gels.   
 The trend seen above in the analysis of TbpA protein expression is very similar to the one 
seen here for TbpA RNA expression (Figure 7A). The amount of TbpA-specific RT-PCR 
product looks roughly equivalent across all strains under iron-deplete conditions. However, the 
amount of TbpA-specific RT-PCR product in the misR strain was much greater than in the wild 
type or complement strains in iron-replete conditions (Figure 7A). This indicates that MisR is 
down-regulating the expression of TbpA under iron-replete conditions, and this effect is lost 
when MisR is not present. The same trend is seen at the 4 hour time point (Figure 7B). The trend 
seen above in the analysis of TbpB protein expression is very similar to the one seen here for 
TbpB-specific transcript levels (Figure 8A). The amount of TbpB-specific RT-PCR product 
looks roughly equivalent across all strains under iron-depleted conditions. However, the amount 
of TbpB-specific RT-PCR product in the misR strain was much greater than in the wild type or 
complement strains in iron-replete conditions (Figure 8A). This indicates that MisR is down-
regulating the expression of TbpA under iron-replete conditions, and this effect is lost when  
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Figure 7. MisR regulated TbpA RNA expression. Strains were grown for 2 hours (A) and 4 
hours (B) after doubling in iron-replete and iron-depleted conditions. Total RNA was isolated 
and reverse transcribed. Part of TbpA was amplified from the cDNA and detected using 
ethidium bromide staining of 2.5% agarose gels. The expected product size of the TbpA 
amplicon was 343 bp. The same part of TbpA was amplified from chromosomal DNA and 
loaded on the far right for size comparison. Molecular mass markers are shown on the left and 
right. 
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Figure 7. MisR regulated TbpA RNA expression. 
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Figure 8. MisR regulated TbpB RNA expression. Strains were grown for 2 hours (A) and 4 
hours (B) after doubling in iron-replete and iron-depleted conditions. Total RNA was isolated 
and reverse transcribed. Part of TbpB was amplified from the cDNA and detected using 
ethidium bromide staining of 2.5% agarose gels. The expected product size of the TbpB 
amplicon was 360 bp. The same part of TbpA was amplified from chromosomal DNA and 
loaded on the far right for size comparison. Molecular mass markers are shown on the left and 
right. 
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MisR is not present. At 4 hours post doubling, the same trend is seen (Figure 8B). At both 2 and 
4 hours post doubling, the difference in the amount of TbpB-specific RT-PCR product present 
under iron-replete conditions in each strain is much more pronounced than in the analysis of 
TbpA. The band representing TbpB-specific RT-PCR product in the wild type and complement 
strains is very faint, while the band representing TbpB DNA in the misR mutant strain is much 
darker. The difference between these bands is much more pronounced for TbpB, especially at the 
4 hour time point. This could indicate that MisR plays a larger role in regulating TbpB than 
TbpA. Also, the trend seen for protein expression at the 2 hour time point for both TbpA and 
TbpB is lost at 4 hours, while the trend seen for the analysis of RNA expression holds for both 
time points. 
III. Characterization of TdfJ 
 TdfJ is a largely uncharacterized TBDT expressed by N. gonorrhoeae. TdfJ is iron 
induced (30) and is present in all commensal and pathogenic Neisseriae. The meningococcal 
homologue of TdfJ is known as ZnuD, and it has been demonstrated to facilitate zinc acquisition 
(83). Bactericidal antibodies were induced in mice immunized with outer membrane vesicles 
from a strain overexpressing ZnuD. Also, ZnuD-specific antibodies were detected in the sera of 
patients recovering from meningococcal infection (83). TdfJ is a potential vaccine target because 
it is surface exposed, well conserved, immunogenic, and is present in all strains of N. 
gonorrhoeae to date. Therefore, research on the function of gonococcal TdfJ is warranted. Based 
on sequence similarity to other heme transporters, it was hypothesized that TdfJ would bind 
hemin when expressed in E. coli and when overexpressed in its native organism.  
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A. Characterization of TdfJ antisera 
 TdfJ antisera was produced for use in future studies. Amino acid sequences in putatively 
surface exposed loops of TdfJ were identified and used make peptides. New England Peptide 
generated the peptides, conjugated the peptides to keyhole limpet hemocyanin (KLH), and 
subsequently immunized four guinea pigs. Peptide 1 (Ac-KRLPDSHADSQTGSIC-amide) is 
located in putative loop 2, and peptide 2 (Ac-VRVEKQKASIRYDKAC-amide) is located in 
putative loop 5 of TdfJ. Guinea pigs 116 and 117 were immunized with peptide 1, yielding 
serum 116 and serum 117. Guinea pigs 118 and 119 were immunized with peptide 2, yielding 
serum 118 and serum 119. After immunization, pre-immunization and post-immunization 
samples from each guinea pig were sent from New England Peptide. Western blots were 
performed with each of the samples in order to assess whether or not the sera reacted specifically 
with TdfJ. Whole cell lystates, provided by another lab member, were prepared from the 
following strains grown in iron-replete and iron-depleted conditions, or in the presence or 
absence of IPTG: FA1090 (wild type), MCV407 (tdfJˉ), MCV412 (tdfJc), and FA1090 sarkosyl 
insoluble outer membrane preparations (OMP). MCV407 cannot express TdfJ and was therefore 
used as a negative control. The whole cell lysates and OMPs were subjected to SDS-PAGE and 
subsequently transferred to nitrocellulose membranes. Following transfer, one membrane was 
probed with the each pre-immunization serum, and another membrane was probed with each 
post-immunization serum. The blots were then developed using the NBT/BCIP system.  
 Pre-immunization serum from guinea pig 116 used at a dilution of 1:50 did not detect 
anything on the membrane (Figure 9A). However, post-immunization serum used at the same 
dilution detected TdfJ in the induced and uninduced complement, as well as in the OMP under 
iron-replete conditions (Figure 9B). TdfJ is approximately 80 kD, so the bands are the  
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Figure 9. Serum 116 reacted specifically with TdfJ. Strains grown in iron-replete or iron-
depleted conditions, or in the presence (IN) or absence (UN) of IPTG, were subjected to SDS-
PAGE and subsequently transferred to nitrocellulose membranes. The membranes were 
probed with pre-immunization serum 116 (A) or post-immunization serum 116 (B). TdfJ is 
approximately 80 kD in size. Molecular mass markers are shown on the left. 
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Figure 9. Serum 116 reacted specifically with TdfJ.  
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appropriate size. TdfJ was not detected in the tdfJˉ strain, and surprisingly, was also not detected 
in the wild type strain under iron-replete or iron-depleted conditions. These results indicate that 
serum 116 reacts specifically with TdfJ. The intensity of the bands, coupled with the fact that 
TdfJ was not detected in the wild type strain, indicate that the complemented strain (MCV412) 
overexpressed TdfJ.  
 Pre-immunization serum from guinea pig 117 used at a dilution of 1:50 did not detect 
anything on the membrane (Figure 10A). There are very faint bands present in all lanes, but they 
are not same size as TdfJ, and are therefore non-specific. Post-immunization serum used at the 
same dilution detected TdfJ in the induced and uninduced complement, as well as in the OMP 
under iron-replete and iron-depleted conditions (Figure 10B). The band is more intense in the 
+Fe OMP than the –Fe OMP lane, demonstrating that TdfJ is iron induced. Again, TdfJ was not 
detected in the tdfJˉ strain or in the wild type strain under iron-replete or iron-deplete conditions. 
These results indicate that serum 117 reacts specifically with TdfJ. 
 Pre-immunization serum from guinea pig 118 used at a dilution of 1:50 did detect bands 
in every lane, but they are not same size as TdfJ, and are therefore non-specific. (Figure 11A). 
Post-immunization serum used at the same dilution detected TdfJ in the induced and uninduced 
complement, as well as in the OMP under iron-replete and iron-deplete conditions (Figure 11B). 
The band is more intense in the +Fe OMP than the –Fe OMP lane, demonstrating that TdfJ is 
iron induced. Again, TdfJ was not detected in the tdfJˉ strain or in the wild type strain under 
iron-replete or iron-depleted conditions. These results indicate that serum 118 reacts specifically 
with TdfJ. 
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Figure 10. Serum 117 reacted specifically with TdfJ. Strains grown in iron-replete or iron-
depleted conditions, or in the presence (IN) or absence (UN) of IPTG, were subjected to SDS-
PAGE and subsequently transferred to nitrocellulose membranes. The membranes were 
probed with pre-immunization serum 117 (A) or post-immunization serum 117 (B). TdfJ is 
approximately 80 kD in size. Molecular mass markers are shown on the left. 
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Figure 10. Serum 117 reacted specifically with TdfJ.  
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Figure 11. Serum 118 reacted specifically with TdfJ. Strains grown in iron-replete or iron-
depleted conditions, or in the presence (IN) or absence (UN) of IPTG, were subjected to SDS-
PAGE and subsequently transferred to nitrocellulose membranes. The membranes were 
probed with pre-immunization serum 118 (A) or post-immunization serum 118 (B). TdfJ is 
approximately 80 kD in size. Molecular mass markers are shown on the left. 
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Figure 11. Serum 118 reacted specifically with TdfJ. 
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 Before analyzing the pre and post-immunization sera from guinea pig 119, the TdfJ 
complement strain was regrown in order to ascertain why TdfJ was being detected in both the 
induced and uninduced MCV412 samples. The newly prepared MCV412 whole cell lysates were 
used in the analysis of pre and post-immunization sera from guinea pig 119. Pre-immunization 
serum from guinea pig 119 used at a dilution of 1:50 did not detect anything on the membrane 
(Figure 12A). Post-immunization serum used at the same dilution detected TdfJ in the induced 
complement, as well as in the OMP under iron-replete and iron-deplete conditions (Figure 12B). 
The band is more intense in the +Fe OMP than the –Fe OMP lane, demonstrating that TdfJ is 
iron induced. Again, TdfJ was not detected in the tdfJˉ strain or in the wild type strain under 
iron-replete or iron-deplete conditions. TdfJ was also not detected in the uninduced complement 
strain for the first time. Based on this result it is assumed that the MCV412 whole cell lysates 
provided initially were mislabeled. As a whole, these results indicate that serum 119 reacts 
specifically with TdfJ. 
 Overall, the initial analysis revealed specificity to the given peptide for each sera. 
However, the sera were unable to detect TdfJ in the wild type strains grown under iron-replete or 
iron-depleted conditions. For this reason, all four guinea pigs were given a booster with a 
different carrier protein. Following the booster, final serum 116 and serum 118 were used to 
probe both +Fe wild type and induced MCV412 tdfJc whole cell lysates. Both sera were tested 
using a range of different dilutions: 1:5, 1:10, 1:50, 1:100, 1:500, 1:1,000, and 1:5,000.  Serum 
116 and serum 118 did not efficiently detect TdfJ in wild type whole cell lysates, even after the 
booster (Figure 13). However, a very faint band was detected using a 1:5 dilution of serum 118. 
This could simply indicate that expression of TdfJ under wild type conditions is low. Serum 116 
and serum 118 did detect TdfJ in the tdfJc whole cell lysate, though serum 116 did so much more 
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Figure 12. Serum 119 reacted specifically with TdfJ. Strains grown in iron-replete or iron-
depleted conditions, or in the presence (IN) or absence (UN) of IPTG, were subjected to SDS-
PAGE and subsequently transferred to nitrocellulose membranes. The membranes were 
probed with pre-immunization serum 119 (A) or post-immunization serum 119 (B). TdfJ is 
approximately 80 kD in size. Molecular mass markers are shown on the left. 
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Figure 12. Serum 119 reacted specifically with TdfJ.  
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Figure 13. Serum 116 and 118 did not efficiently detect TdfJ in wild type whole cell 
lysate. Wild type FA1090 whole cell lysate, grown under iron-replete conditions, was 
subjected to SDS-PAGE and subsequently transferred onto a nitrocellulose membrane. The 
membrane was probed with serum 116 and serum 118 and developed with the NBT/BCIP 
system. The black arrow indicates the presence of a faint band at the highest concentration of 
serum 118.  
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Figure 13. Serum 116 and 118 did not efficiently detect TdfJ in wild 
type whole cell lysate.  
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efficiently (Figure 14). Serum 116 was capable of detecting TdfJ at a dilution as low as 1:5,000. 
On the other hand, serum 118 was capable of detecting TdfJ at a dilution as low as 1:500. Both 
sera worked, but serum 116 was much more sensitive.  
 Based on the information gained from testing the final sera 116 and 118 at many 
dilutions, one last test was run in order to establish a working concentration for each serum to be 
used in future experiments. Again, induced and uninduced MCV412 whole cell lysates, along 
with OMPs prepared under iron-replete and iron-deplete conditions, were subjected to SDS-
PAGE and subsequently transferred onto nitrocellulose membranes. Following the transfer, the 
membranes were probed with the final sera. Final serum 116 and serum 117 were used at a 1:200 
dilution, while final serum 118 and serum 119 were used at a 1:100 dilution. A 1:3,000 dilution 
of the secondary rabbit anti-guinea pig AP (Southern Biotech) was used in order to increase 
sensitivity. Final serum 116 detected TdfJ in the induced complement strain, and in both the +Fe 
and –Fe OMPs (Figure 15A). Final serum 117 also detected TdfJ in the induced complement 
strain, and in both the +Fe and –Fe OMPs (Figure 15B). Final serum 118 and serum 119 appear 
to detect TdfJ at a similar level of sensitivity. Serum 118 (Figure 15C) and serum 119 (Figure 
15D) both detected TdfJ in the induced complement strain and in the +Fe OMP, however both 
failed to detect TdfJ in the –Fe OMP at this dilution. Based on these results, serum 117 appears 
to be the best and most sensitive of the four sera. 
 In an effort to detect TdfJ in wild type whole cell lysate, FA1090 (wild type) and 
MCV407 (tdfJˉ) whole cell lysates, grown under iron-replete and iron-depleted conditions, were 
subjected to SDS-PAGE and subsequently transferred to a nitrocellulose membranes. Following 
transfer, the membrane was probed with primary serum 117 at a dilution of 1:200. Primary 
serum 117 was detected using goat anti-guinea pig HRP (Southern Biotech) and developed using   
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Figure 14. Serum 116 and 118 detected TdfJ in MCV412 whole cell lysate. MCV412 
(tdfJc) whole cell lysate, induced with IPTG, was subjected to SDS-PAGE and subsequently 
transferred onto a nitrocellulose membrane. The membrane was probed with serum 116 and 
serum 118 and developed with the NBT/BCIP system. The black arrows indicate TdfJ 
specific bands. 
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Figure 14. Serum 116 and 118 detected TdfJ in MCV412 whole 
cell lysate.  
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Figure 15. Final sera detected TdfJ in induced MCV412 and OMPs. Strains grown in 
iron-replete or iron-deplete conditions, or in the presence (IN) or absence (UN) of IPTG, were 
subjected to SDS-PAGE and subsequently transferred to nitrocellulose membranes. The 
membranes were then probed with serum 116 (A), serum 117 (B), serum 118 (C), or serum 
119 (D). TdfJ is approximately 80 kD in size. Molecular mass markers are shown on the left. 
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Figure 15. Final sera detected TdfJ in induced MCV412 and OMPs. 
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ECL. Through the use of a more sensitive detection system, detection of TdfJ with serum 117 
was visualized (Figure 16). TdfJ was not detected in MCV407, which served as the negative 
control. Based on this results, blots would need to be developed using ECL in order to detect 
TdfJ in wild type whole cell lysate. 
B. Expression of TdfJ in E. coli 
 TdfJ was expressed in E. coli in order to assess its possible role in heme binding. TdfJ, 
from start site 1 (SS1) and start site 2 (SS2), was cloned into the pBAD-TOPO vector 
(Invitrogen). TOP10 E. coli cells (Invitrogen) were transformed and subsequently screened. 
After transformants were verified, a pilot expression experiment was performed using various 
concentrations of L-arabinose (Sigma Aldrich) to induce expression.  The empty vector served as 
the negative control, as it does not contain the tdfJ sequence. Overnight cultures were used to 
inoculate LB containing the appropriate antibiotics, and the cultures were grown to an OD600 
=0.5. Cultures were induced with 0%, 0.002%, or 0.02% arabinose. After a four hour induction, 
whole cell lystates were made. Whole cell lysates were subjected to SDS-PAGE and 
subsequently transferred to a nitrocellulose membrane. Induced MCV412 (tdfJc) whole cell 
lysate was used as a positive control. The membrane was probed with anti-TdfJ serum 117 and 
developed using the NBT/BCIP system. Expression of TdfJ was almost completely absent at 0% 
arabinose, although there is a very faint band present for both SS1 and SS2 (Figure 17). This 
indicates fairly tight control of TdfJ expression by the PBAD promoter. Expression of TdfJ from 
SS1 and SS2 was present at both 0.002% and 0.02% arabinose, but expression was optimal when 
induced with 0.02% arabinose (Figure 17). There was no TdfJ expressed by the empty vector 
control.  
  
  
 75  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 16. TdfJ detected in wild type whole cell lysate when developed with ECL. 
FA1090 (wild type) and MCV407 (tdfJˉ) whole cell lysates, grown under iron-replete and 
iron-deplete conditions, were subjected to SDS-PAGE and subsequently transferred to a 
nitrocellulose membranes. Following transfer, the membrane was probed with serum 117 at a 
dilution of 1:200 and developed using ECL. The black arrow indicates TdfJ specific bands. 
Approximate positions of the molecular mass markers are shown on the left. 
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Figure 16. TdfJ detected in wild type 
whole cell lysate when developed with 
ECL.  
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Figure 17. L-arabinose Induction of TdfJ expression in E. coli. TdfJ, from SS1 and SS2, 
was cloned into the pBAD-TOPO vector and TOP10 E. coli cells were subsequently 
transformed. After transformants were verified, expression of TdfJ was induced by various 
levels of L-arabinose. Whole cell lysates were made, subjected to SDS-PAGE, transferred to 
nitrocellulose, and probed with anti-TdfJ serum 117. The empty vector served as the negative 
control, while induced MCV412 (tdfJc) served as the positive control. Approximate position 
of the molecular mass marker is shown on the left. 
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Figure 17. L-arabinose Induction of TdfJ expression in E. coli.  
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 Whole cell dot blots were performed in order to assess surface exposure of TdfJ as 
expressed in E. coli. Overnight cultures were used to inoculate LB containing the appropriate 
antibiotics, and the cultures were grown to an OD600 = 0.5. At that point cultures were induced 
with 0%, 0.00002%, 0.0002%, 0.002%, 0.2%, or 0.02% arabinose. After a four hour induction, 
cultures were standardized and added in duplicate to the S&S Minifold I Dot Blotter (Whatman) 
containing a nitrocellulose membrane. The membrane was allowed to dry for one hour and 
stored overnight. The membrane was probed with anti-TdfJ serum 117 at a 1:200 dilution and 
developed using the NBT/BCIP system. FA1090 (wild type), induced MCV412 (tdfJc), and 
MCV407 (tdfJˉ) were also grown and used as controls.  
 TdfJ was surface exposed when expressed from SS1 in E. coli (Figure 18A). Expression 
of TdfJ increased as the concentration of arabinose increased. At 0.2% arabinose the signal is the 
most intense, however at this concentration of arabinose the bacteria were lysing. Lysis products 
could be seen in the culture and the final density is much lower than in the other conditions. This 
indicates that expression of TdfJ at this level is toxic to the bacteria. There was signal in the 0% 
arabinose condition, indicating leaky expression from the inducible promoter. TdfJ was also 
surface exposed when expressed from SS2 in E. coli (Figure 18B). Again, expression of TdfJ 
increased as the concentration of arabinose increased, with the most intense signal seen in the 
0.2% arabinose condition. There was an even more intense signal in the 0% arabinose condition, 
indicating that expression from the inducible promoter is leakier when expressing TdfJ from 
SS2. There was a small amount of signal in the wild type condition (Figure 18C). TdfJ appeared 
to be surface exposed in the MCV412 complement strain (Figure 18C). Lastly, there was no 
signal in the MCV407 (tdfJˉ) negative control.  
 
  
 80  
  
 
  
Figure 18. TdfJ expressed in E. coli was surface exposed. E. coli TdfJ SS1 cultures (A) and 
TdfJ SS2 cultures (B) were induced with 0%, 0.00002%, 0.0002%, 0.002%, 0.2%, or 0.02% 
arabinose. After a four hour induction, cultures were standardized and added to the dot blotter 
containing a nitrocellulose membrane. The membrane was allowed to dry for one hour, stored 
overnight, and probed with anti-TdfJ serum 117 at a 1:200 dilution. The membrane was 
developed using the NBT/BCIP system. Gonococcal strains FA1090 (wild type), induced 
MCV412 (tdfJc), and MCV407 (tdfJˉ) were used as controls (C). 
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Figure 18. TdfJ expressed in E. coli was surface exposed.  
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 After confirming that TdfJ was surface exposed when expressed by E. coli, the rest of the 
E. coli expression strains were tested. E. coli expressing TbpA, TdfF, TdfG, and TdFH were also 
used in subsequent experiments, therefore surface exposure of these proteins was assessed in the 
same manner. Overnight cultures were used to inoculate LB containing the appropriate 
antibiotics, and the cultures were grown to an OD600 = 0.5. At that point cultures were induced 
with arabinose or IPTG. After a two or four hour induction, cultures were standardized and 
added in triplicate to the S&S Minifold I Dot Blotter (Whatman) containing a nitrocellulose 
membrane. The membrane was allowed to dry for one hour and stored overnight. To detect TdfF, 
TdfG, TdfH and TdfJ, the membrane was probed with protein specific antibodies and developed 
using the NBT/BCIP system. To detect TbpA, the membrane was probed with HRP labeled 
transferrin and developed using the Opti-4CN system (Biorad). The empty vector control in both 
the TOP10 and BL21 background was included and probed with each antibody (Figure 19). 
There was background binding in all uninduced conditions, but the signal is comparable to the 
signal in the empty vector controls (Figure 19).  The signal from each expression strain was the 
most intense in the induced condition, indicating that each protein was surface exposed when 
expressed from its respective E. coli expression strain (Figure 19). 
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Figure 19. TbpA, TdfF, TdfG, TdfH, and TdfJ were surface exposed when expressed in 
E. coli. E. coli cultures were induced with IPTG or arabinose. After a two or four hour 
induction, cultures were standardized and added to the dot blotter containing a nitrocellulose 
membrane. The membrane was allowed to dry for one hour, and stored overnight. The 
membrane was probed with protein specific antibodies to detect TdfF, TdfG, TdfH, and TdfJ 
and developed with the NBT/BCIP system. To detect TbpA, the membrane was probed with 
HRP labeled transferrin and developed with the Opti-4CN system. The empty vector control 
in both the TOP10 and BL21 background was included and probed with each antibody. The 
“+” symbol indicates induced cultures, while the “-“symbol indicates uninduced cultures.  
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Figure 19. TbpA, TdfF, TdfG, TdfH, and TdfJ were surface exposed 
when expressed in E. coli.  
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C. Hemin Sedimentation Assays 
 Heme sedimentation assays were performed in order to assess TdfJ’s ability to bind 
hemin when expressed by E. coli. E. coli expressing TbpA, TdfF, TdfG, and TdfH were included 
as controls. Briefly, cultures were induced by the addition of arabinose or IPTG and allowed to 
grow for two or four hours. After induction of protein expression, aliquots were washed once 
with PBS containing 5% DMSO, centrifuged, resuspended in 1 mL of PBS containing 5% 
DMSO, and standardized to an OD600 = 1.0. Cultures were then allowed to incubate with 15 µM 
or 20 µM hemin for one hour at room temperature in a v-bottom 96-well plate. After one hour 
the 96-well plate was centrifuged, and the supernatant from each well was transferred to a flat-
bottom 96-well plate. The OD405 of the supernatants were read and recorded by a plate reader. 
Wells containing hemin and no cells were used as the 100% saturated controls, meaning that 
100% of the hemin was present in the supernatant and was not bound to cells. Percent hemin 
bound was determined by the decrease in absorbance of the supernatant as compared to the 
100% saturated or unbound control. 
1. Alignment of TdfJ, TbpA, and FetA with Representative Heme Receptors 
 The FRAP and NPNL motifs have been shown to be characteristic of receptors known to 
bind heme or hemoproteins (13). The conserved histidine residue that falls in between the two 
motifs has been shown to be critical for heme utilization by HmuR in Porphyromonas gingivalis 
(54) and HemR in Yersinia enterocolitica (13). The gonococcal TBDTs were aligned with other 
representative heme receptors using ClustalW. The multiple sequence alignment was then 
uploaded to Jalview, and the presence of the FRAP motif, the conserved histidine, and the NPNL 
motif was assessed. Of the gonococcal TBDTs analyzed, only TbpA, FetA, and TdfJ contained 
one or more of these characteristics (Figure 20). TdfJ contains the FRAP motif, the conserved  
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Figure 20. Alignment of TbpA, FetA, and TdfJ with representative heme receptors. The 
gonococcal TBDTs were aligned with representative heme receptors using ClustalW. The 
conserved FRAP and NPNL motifs are marked by black lines. The identical residues within 
those motifs are marked with an asterisk. The highly conserved histidine residue is marked 
with a pound sign. The numbers following the identifier are the residue numbers within each 
gene. Sd, Shigella dysenteriae; Ye, Yersinia enterocolitica; Hi, Haemophilus influenzae; 
Hd, Haemophilus ducreyi; Nm, Neisseria meningitidis; Ng, Neisseria gonorrhoeae; Mc, 
Moraxella catarrhalis; Sm, Serratia marcescens; Pg, Porphyromonas gingivalis. 
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>Sd_ShuA/424-475  LMLFGSYAQAFRAPTMGEMYND-SKHFSI---GRFYTNYWVPNPNLRPETNETQEY 
>Ye_HemR/437-491  LMLFGSYAQAFRAPTMGEMYND-SKHFSMNIMGNTLTNYWVPNPNLKPETNETQEY 
>Hi_HhuA/751-796  LRLQAKYGKAFRAPTSDEIYFT-FLHPDF---------SIRPNRDLQAETAKTKEL 
>Hi_HgpA/803-848  LRLQAKYSKGFRAPTSDEIYFT-FKHPDF---------SIQPNRDLQPETAKTKEL 
>Hd_HupA/682-727  LKIQAKYATGFRAPTSDEIYFV-FQHPSF---------SIYPNLYLKAERSKNKEV 
>Nm_HpuB/525-570  LHLLAKYSTGFRAPTSDETWLL-FPHPDF---------YLKANPNLKAEKAKNWEL 
>Nm_ZnuD/499-546  HKLSLTASHQERLPSTQELYAH-GKHVATN-------TFEVGNKHLNKERSNNIEL 
>Ng_TdfJ/505-552  HKLSLTASHQERLPSTQELYAH-GKHVATN-------TFEVGNKHLNKERSNNIEL 
>Ng_TbpA/635-677  LDLTYRTSTGFRLPSFAEMYGW-RSGGKIK------------AVKIDPEKSFNKEA 
>Ng_FetA/466-510  WSFSASHNYASRSPRLYDALQT---HGKRG--------IISIADGTKAERARNTEI 
>Mc_HumA/556-603  HKLSLNLSHQERLPNAQELYAH-GMHLATN-------SFEIGNRFLNKEKSNNIDL 
>Nm_HmbR/476-521  WRVGYDITSGYRVPNASEVYFT-YNHGSGN---------WLPNPNLKAERSTTHTL 
>Sm_HasR/612-658  LELYTTYGKSWRPPAITETLTNGSAHSSST---------QYPNPFLQPERSRAWEV 
>Pg_HmuR/410-455  VTNRLSYAEGYRAPSLQEMYFF-FNHGAFF---------IYGNPDLKPEKSRMLSY 
# 
*   * *     * 
Figure 20. Alignment of TbpA, FetA, and TdfJ with representative heme receptors.  
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histidine residue, and the NPNL motif. FetA contains the FRAP motif and the conserved 
histidine residue. TbpA only contains the FRAP motif. However, there are two highly conserved 
histidine residues in surface exposed loops 2 and 11 that could participate in hemin binding 
(Figure 21). 
2. TdfJ and TbpA Bind Hemin when Expressed in E. coli 
 TdfJ, expressed from SS1 and SS2, bound hemin in the 15 µM hemin condition (Figure 
22B). In the uninduced 15 µM hemin condition, none of the proteins exhibited hemin binding 
above background levels (Figure 22A). However, when TdfJ expression was induced from SS1, 
~11% of total hemin was bound (Figure 22B). When TdfJ expression was induced from SS2, 
~12% of total hemin was bound (Figure 22B). Surprisingly, TbpA also bound hemin in the 15 
µM hemin condition (Figure 22B). When TbpA expression is induced, ~7% of total hemin is 
bound (Figure 22B). Hemin binding to TdfJ (SS1 and SS2) and TbpA is statistically significant 
as compared to the empty vector control. 
 TdfJ, expressed from SS1 and SS2, also bound hemin in the 20 µM hemin condition 
(Figure 23B). In the uninduced 20 µM hemin condition, none of the proteins exhibited hemin 
binding above background levels (Figure 23A). However, when TdfJ expression was induced 
from SS1, ~23% of total hemin was bound (Figure 23B). When TdfJ expression was induced 
from SS2, ~18% of total hemin was bound (Figure 23B). Again, TbpA also bound hemin in the 
20 µM hemin condition. When TbpA expression was induced, ~20% of total hemin is bound 
(Figure 23B). Hemin binding to TdfJ (SS1 and SS2) and TbpA was statistically significant as 
compared to the empty vector control. 
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Figure 21. 2-D Topology Model of TbpA. The figure depicts the putative 2-D topology of 
TbpA. The grey dotted lines indicate the outer membrane and the cytoplasmic membrane. The 
red rectangle indicates the location of the FRAP motif. The red arrows indicate the location of 
the conserved histidine residues. L = loop. 
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Figure 21. 2-D Topology Model of TbpA.  
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Figure 22. TdfJ and TbpA bound hemin in the 15 µM hemin condition when expressed 
in E. coli. Cultures were induced by the addition of arabinose or IPTG and allowed to grow 
for two or four hours. After induction of protein expression, cultures were washed once with 
PBS containing 5% DMSO and standardized to an OD600 = 1.0. Cultures were incubated with 
15 µM hemin for one hour at room temperature in a v-bottom 96-well plate. After one hour 
the 96-well plate was centrifuged, and the supernatant from each well was transferred to a 
flat-bottom 96-well plate. The OD405 of the supernatants were read and recorded by a plate 
reader. Results from both uninduced bacteria (A) and induced bacteria (B) are shown. Wells 
containing hemin and no cells were used as the 100% saturated controls. Percent hemin bound 
was determined by the decrease in absorbance of the supernatant as compared to the 100% 
saturated or unbound control. The data represents the means and standard deviations of one 
experiment performed in quadruplicate. Statistically significant differences were determined 
by paired Student’s t test, with two tailed hypotheses. Statistically significant differences are 
marked with asterisks (*, P<0.05). 
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Figure 22. TdfJ and TbpA bound hemin in the 15 µM hemin condition 
when expressed in E. coli.  
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Figure 23. TdfJ and TbpA bound hemin in the 20 µM hemin condition when expressed 
in E. coli. Cultures were induced by the addition of arabinose or IPTG and allowed to grow 
for two or four hours. After induction of protein expression, cultures were washed once with 
PBS containing 5% DMSO and standardized to an OD600 = 1.0. Cultures were incubated with 
20 µM hemin for one hour at room temperature in a v-bottom 96-well plate. After one hour 
the 96-well plate was centrifuged, and the supernatant from each well was transferred to a 
flat-bottom 96-well plate. The OD405 of the supernatants were read and recorded by a plate 
reader. Wells containing hemin and no cells were used as the 100% saturated controls. 
Percent hemin bound was determined by the decrease in absorbance of the supernatant as 
compared to the 100% saturated or unbound control. The data represents the means and 
standard deviations of one experiment performed in quadruplicate. Statistically significant 
differences were determined by paired Student’s t test, with two tailed hypotheses. 
Statistically significant differences are marked with asterisks (*, P<0.05). 
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Figure 23. TdfJ and TbpA bound hemin in the 20 µM hemin condition 
when expressed in E. coli.  
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 In both the 15 µM and 20 µM hemin conditions there were negative results when the 
strains were uninduced, or when the induced strains were unable to bind hemin. The data shown 
represents the inverse of the percent hemin unbound, which is representative of the amount of 
hemin left in the supernatant as compared to the 100% unbound control, which contains no cells. 
Therefore, the negative data indicates an increased amount of hemin present in the supernatant as 
compared to the 100% unbound control. This phenomena is likely occurring due to the release of 
hemin from the cells as a result of small scale lysis. This manifests as negative data when the 
cells are unable to bind hemin, thus causing an overall increase in absorbance. This is also likely 
occurring in the induced expression strains shown to bind hemin, but the increase is not seen due 
to their ability to bind hemin and decrease the overall amount of hemin left in the supernatant.   
3.  Hemin Binding Phenotype of TdfJ Inconclusive when Overexpressed in N. gonorrhoeae. 
 The ability of TdfJ to bind hemin was assessed in its native organism. The assay was 
performed in the same way, except the 96-well plate was kept at 37°C with the addition of 5% 
CO2 during the hour long incubation step. The following strains were used: induced and 
uninduced MCV412 (tdfJc) and MCV411 (nspAc). MCV411 was included as a negative control. 
MCV411 was also a useful control because it is overexpressing a surface exposed outer 
membrane protein. In the presence of 15 µM hemin, all of the conditions resulted in a relatively 
high amount of hemin binding, but none of the conditions were significantly different from the 
others (Figure 24A). Induced MCV412, which overexpresses TdfJ, bound hemin at a similar 
level to its uninduced counterpart. MCV411 bound hemin at approximately the same level as 
induced and uninduced MCV412 (Figure 24A). There were no statistically significant 
differences in the percent hemin bound between the three conditions. In the presence of 20 µM 
hemin, the same was true (Figure 24B). In the 20 µM hemin condition, hemin binding was 
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Figure 24. Hemin binding phenotype of TdfJ inconclusive when overexpressed in N. 
gonorrhoeae. Cultures were induced by the addition of arabinose or IPTG and allowed to 
grow for two or four hours. After induction of protein expression, cultures were washed once 
with PBS containing 5% DMSO and standardized to an OD600 = 1.0. Cultures were incubated 
with 15 µM (A) 20 µM (B) hemin for one hour at room temperature in a v-bottom 96-well 
plate. After one hour the 96-well plate was centrifuged, and the supernatant from each well 
was transferred to a flat-bottom 96-well plate. The OD405 of the supernatants were read and 
recorded by a plate reader. Wells containing hemin and no cells were used as the 100% 
saturated controls. Percent hemin bound was determined by the decrease in absorbance of the 
supernatant as compared to the 100% saturated or unbound control. The data represents the 
means and standard deviations of one experiment performed in quadruplicate. 
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Figure 24. Hemin binding phenotype of TdfJ inconclusive when 
overexpressed in N. gonorrhoeae.  
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present in all strains, but there were no statistically significant differences in the percent hemin 
bound between the three conditions. The amount of hemin binding to gonococci was generally 
higher than hemin binding to the E. coli strains, despite protein expression. This indicates a high 
level of background hemin binding due to some surface characteristic of the gonococcus, or the 
presence of other hemin binding surface molecules.  
D. Ribonuclease Leakage Assay 
 As an additional control, an RNase leakage assay was performed to ensure that hemin 
binding was not an artifact of protein overexpression. Although we hypothesized that TdfJ would 
bind hemin, the results that indicated that TbpA bound hemin were completely unexpected. The 
Ribonuclease (RNase) leakage assay was performed in order to rule out the possibility that 
membrane permeabilization was responsible for hemin binding. The RNase leakage assay had 
been performed using the pUNCH412 TbpA E. coli expression strain and the strain was shown 
to leak RNase from its outer membrane. Since the TbpA expression strain had been shown to 
leak RNase, we tested all of the other expression strains. Although the assay is in no way 
quantitative, the qualitative results would help establish confidence in the hemin sedimentation 
assay results. If all strains appeared to leak RNase this would suggest that membrane 
permeabilization is not responsible for the hemin binding and that the results are indicative of 
specific hemin binding. However, if only the TdfJ and TbpA expression strains leaked RNA, this 
might indicate that hemin binding is a nonspecific phenomenon caused by the expression of a 
large, foreign protein on the outer membrane.  
 Leaking RNase was detected by plating each E. coli expression strain on LB plates 
containing RNA and inducing protein expression with arabinose or IPTG. After 24 hours of 
growth, the plates were flooded with 0.1 N HCl and photographed. The HCl caused any RNA 
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remaining in the agar to precipitate, causing the agar to look opaque or light. Areas in the agar 
where the RNA has been degraded by RNases appear clear or dark. The TbpA expression strain 
was used as the positive control because it is known to leak RNase. The empty vector control 
was used as the negative control. This experiment was performed twice with the same outcome, 
and the results from one replicate were photographed (Figure 25). All strains, except for the 
empty vector control, leaked RNase to various degrees. Dark or clear areas indicating RNase 
leakage are marked with a red arrow. The phenomena is best viewed at the edge of dense colony 
growth.  
E. Hemin Binding Blots  
 Hemin binding blots were performed in order identify any gonococcal outer membrane 
proteins with the ability to bind hemin via a different method. FA1090 sarkosyl insoluble OMPs, 
grown under iron-replete or iron-deplete conditions, were subjected to SDS-PAGE on a 7.5% 
gel, and subsequently transferred to a nitrocellulose membrane. The membrane was probed with 
TBS containing 10-6 M hemin for 1.5 hours. Bound hemin was visualized via its inherent 
peroxidase activity using ECL. The blot was exposed to autoradiographic film for approximately 
20 seconds. Bands representing TdfJ and TbpA are not predominate, however there appears to be 
a faint band in the –Fe OMP lane around 100 kD, which is likely TbpA (Figure 26). There is also 
a faint band around 75 or 80 kD in the +Fe OMP, which is likely TdfJ (Figure 26). Surprisingly, 
a much more distinct band appeared at approximately 70 kD.  
 Based on these unexpected results, the experiment was performed again, except this time 
the same OMP samples were run out on duplicate 7.5% and 15% polyacrylamide gels. After 
electrophoresis, one of each percentage gel was transferred onto nitrocellulose, probed with 
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Figure 25. Ribonuclease Leakage Assay. Leaking RNase was detected by plating the TbpA 
expression strain (A), the TdfF expression strain (B), the TdfG expression strain (C), the 
TdfH expression strain (D), the TdfJ (SS1) expression strain (E), the TdfJ (SS2) expression 
strain (F), and the empty vector control strain (G), on LB plates containing RNA and inducing 
protein expression with arabinose or IPTG. After 24 hours of growth, the plates were flooded 
with 0.1 N HCl and photographed. Areas where RNases have degraded the RNA in the agar 
appear clear or dark, and are indicated by the red arrows.  
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Figure 25. Ribonuclease Leakage Assay.  
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Figure 26. A ~70 kD protein in the –Fe OMP bound hemin. Sarkosyl insoluble outer 
membrane preperations were subjected to SDS-PAGE and subsequently transferred to a 
nitrocellulose membrane. The membrane was probed with hemin for 1.5 hours, developed 
with ECL, and exposed to autoradiographic film. Molecular mass markers are shown on the 
left. 
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Figure 26. A ~70 kD protein in the –Fe OMP bound hemin.  
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hemin, developed with ECL, and exposed to autoradiographic film. The remaining gels were 
stained with Coomassie blue overnight, and destained the following day until background 
straining was minimized.  
 After transfer and probing, the 7.5% gel yielded the same results. Faint bands likely 
representing TdfJ and TbpA were seen at 100 kD in the –OMP and 80 kD in the +OMP, 
respectively. Again, a distinct band approximately 70 kD in size was seen (Figure 27A). This 
band was missing in the +Fe OMP lane. The corresponding band on the Coomassie stained gel, 
shown by the arrow, was excised and sent for protein identification at the VCU Mass 
Spectrometry Core (Figure 27B). The 15% gel, after transfer and probing, revealed another 
distinct band approximately 35 kD in size in the –Fe OMP (Figure 28A). This band was 
markedly absent in the +Fe OMP lane. The corresponding band on the Coomassie stained gel, 
shown by the arrow, was also excised and sent for protein identification at the VCU Mass 
Spectrometry Core (Figure 28B). 
  The protein identification results for the smaller, ~35 kD band, were fairly straight 
forward. The protein was putatively identified as ferric binding protein A. FbpA is the 37 kD 
periplasmic binding protein responsible for shuttling the iron released by the transferrin and 
lactoferrin acquisition systems across the periplasm. This periplasmic protein was likely included 
in the sarkosyl insoluble outer membrane preparation because apo-FbpA binds directly and 
specifically TbpA, an outer membrane protein (80). Also, the gonococci express a very large 
amount of FbpA.  
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Figure 27. A ~70 kD protein in the –Fe OMP bound hemin. Sarkosyl insoluble outer 
membrane preperations were subjected to SDS-PAGE in duplicate. Separated proteins was 
subsequently transferred to a nitrocellulose membrane or stained with Coomassie blue. The 
nitrocellulose membrane was probed with hemin for 1.5 hours, developed with ECL, and 
exposed to autoradiographic film. The band in the Coomassie stained gel that corresponded to 
the hemin-binding band was excised and sent for protein identification. This band is indicated 
by a black arrow. Molecular mass markers are shown on the left. 
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Figure 27. A ~70 kD protein in the –Fe OMP bound hemin.  
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Figure 28. A ~35 kD protein in the –Fe OMP bound hemin. Sarkosyl insoluble outer 
membrane preperations were subjected to SDS-PAGE in duplicate. Separated proteins was 
subsequently transferred to a nitrocellulose membrane or stained with Coomassie blue. The 
nitrocellulose membrane was probed with hemin for 1.5 hours, developed with ECL, and 
exposed to autoradiographic film. The band in the Coomassie stained gel that corresponded to 
the hemin-binding band was excised and sent for protein identification. This band is indicated 
by a black arrow. Molecular mass markers are shown on the left. 
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Figure 28. A ~35 kD protein in the –Fe OMP bound hemin.  
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 The protein identification results for the larger, ~70 kD band, were less clear. Many 
proteins were detected in the band, including TbpA and porin, however these proteins are the 
incorrect size. This is likely due to the fact that a 1-D gel analysis was used. The outer membrane 
preparations used were heavily processed and proteins that were the incorrect size were likely 
identified due to the presence of protein fragments in the bands. In order to avoid this 
contamination issue a 2-D gel analysis could be performed.  
 However, there were two matches that were a bit more reasonable: PilQ and FetA. PilQ is 
a ~78 kD protein that functions in type IV pilus organelle biogenesis, which is essential for DNA 
transformation competence in the gonococcus (29). FetA is a ~78 kD protein and is the TBDT 
responsible for the import of ferric enterobactin and other catecholate-type siderophores (14, 43). 
Also, FetA is iron repressed like the ~70 kD band seen in the hemin binding blot.  
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Discussion 
 
 
 
 This study was a multifaceted investigation into the structure, regulation, expression, and 
function of selected TonB-dependent transporters in N. gonorrhoeae. The study had three main 
objectives, the first of which was to investigate the role of two highly conserved regions of TbpB 
in lipidation. It was hypothesized that mutation of one of those conserved regions, the LSAC 
motif, would prevent lipidation of TbpB. The hypothesis was confirmed, as our data indicates 
that the LSAC motif is necessary for lipidation of TbpB. The TbpB LSAC mutant was able to 
produce full length TbpB, however the protein was not lipidated. The second focus was on the 
regulation of TbpA and TbpB by the two component regulatory system MisR/MisS. It was 
hypothesized that the MisR/MisS system played a role in iron-dependent regulation of TbpA and 
TbpB. This hypothesis was confirmed, as our data shows that a MisRˉ strain demonstrates 
dysregulated expression of TbpA and TbpB. The third focus of this study was on the expression 
and function of the largely uncharacterized TBDT TdfJ. Based on sequence similarity to other 
heme transporters, it was hypothesized that TdfJ would bind hemin when expressed in E. coli. 
This hypothesis was also confirmed, as our data shows that E. coli expressing TdfJ are able to 
specifically bind hemin.  
 The first focus of this study was to examine the role of two highly conserved regions of 
TbpB, and examine whether or not they play a role in lipidation. TbpA and TbpB are potential 
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vaccine candidates, so it was important to investigate the roles of the conserved regions of TbpB 
as they might influence lipidation, and thus attachment of the protein to the cell surface. TbpB 
was previously shown to be surface exposed (4) and lipidated (28), however the site of lipidation 
had yet to be elucidated. Also, the roles of two highly conserved amino-terminal regions of TbpB 
had not yet been established. It was hypothesized that the LSAC motif was the site of lipidation 
in TbpB, and our results confirmed this hypothesis. Full length TbpB was expressed and 
lipidated by MCV843 (TbpB ΔGly), showing that the conserved stretch of four glycine residues 
was not important for lipidation. Full length TbpB was produced by MCV839 (TbpB LSAC), 
however it was not lipidated, thus demonstrating the importance of the LSAC motif to the 
lipidation of the protein.  
 Although the conserved glycine residues were not shown to be involved in the lipidation 
of TbpB, MCV843 (TbpB ΔGly) had a significant defect in growth when transferrin was 
provided as the sole iron source (71). This indicates that the glycine residues play an important 
role in transferrin iron acquisition. These results help to shed light on the role of two conserved 
regions within TbpB. These results give us a more detailed understanding of TbpB and how it 
associates with the cell surface, which could aid in the development of new therapies or vaccines 
targeted against infection with N. gonorrhoeae. Also, lipidated proteins are particularly 
immunogenic, so understanding the mechanism of lipidation could help improve 
immunogenicity of a potential vaccine utilizing TbpB (100).  
 The second goal of the study was to assess whether or not the MisR/MisS two component 
regulatory system played a role in regulating TbpA and TbpB. Unpublished RNA-Seq data 
performed by the Shafer lab showed that MisR plays a role in the regulation of tbpA and tbpB 
expression. Under iron replete conditions tbpA expression was repressed 3 fold, while tbpB 
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expression was repressed 5 fold. Also, phosphorylated MisR was shown to bind specifically to 
the region upstream of the tbpBA operon by electrophoretic mobility shift assay. Following this 
result DNA footprinting was performed, and MisR was shown to bind to five distinct sequences 
upstream of the tbpBA operon. Meningococcal MisR/MisS does not regulate TbpA and TbpB 
(91), so it is noteworthy that the system has been demonstrated to bind to and regulate the 
gonococcal transferrin binding proteins. The regions upstream of the Fur box are distinct 
between the two species, and this could be responsible for the difference. The discrepancy in the 
regulation of the well conserved transferrin acquisition between the two species may shed light 
on how the species have evolved to survive optimally in their individual niches.  
 Analysis of both protein and RNA expression revealed that MisR plays a role in 
regulating TbpA and TbpB, especially under iron-replete conditions. Little is known about the 
gonococcal MisR/MisS system, except that it responds to antimicrobial peptides like LL-37. This 
indicates that the two component regulatory system is sensing host signals and regulating 
important virulence factors, like TbpA and TbpB, accordingly. These results also suggest that 
TbpA and TbpB are under the control of two forms of regulation, Fur and MisR/MisS, both of 
which respond to iron availability. The finding that MisR differentially regulates TbpA and 
TbpB according to iron availability exemplifies how important iron and the corresponding 
regulation of iron acquisition proteins is to the gonococcus. Complete knowledge of the complex 
regulatory elements that control the expression of the transferrin binding proteins is essential and 
could shed light on how other important nutrient acquisition systems in N. gonorrhoeae may 
function. If TbpA and TbpB are to be used as vaccine targets, understanding their regulation is 
essential.  
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 MisR/MisS is especially important concerning vaccine and therapeutic development 
because this form of regulation responds to extracellular signals in the host environment. The 
sensor, MisS, resides in the cytoplasmic membrane, and upon exposure to host factors like 
antimicrobial peptides, phosphorylates the response regulator MisR. MisR is then able to bind 
DNA targets upstream of the tbpBA operon. MisR is able to bind to five different sites, and this 
may allow for the formation of a secondary structure which negatively impacts transcription, and 
therefore expression, of these important proteins. This two component regulatory system senses 
the host environment and assists the gonococcus in choosing the appropriate expression of 
different iron acquisition systems. The environment within the host, and therefore the iron 
sources available in the host, changes throughout the many stages of infection, and therefore the 
MisR/MisS system likely plays a role in responding to changes in iron availability in the host. 
Knowledge of how TbpA and TbpB are regulated and expressed during infection in the host is of 
paramount importance. Also, the MisR/MisS system may serve as an immune evasion strategy. 
The repression of the transferrin binding proteins in the presence of LL-37 may be an attempt to 
hide these important, well conserved virulence factors from the immune system, and thus halt 
production of antibodies against the proteins. If these proteins are not optimally expressed during 
certain stages of infection it may impact and direct the development of a vaccine. Perhaps a 
subunit vaccine, including many different TBDTs, would be more effective.  
  The third focus of this study was to better characterize TdfJ. Based on sequence 
similarity to other heme transporters, it was hypothesized that TdfJ would bind hemin when 
expressed in E. coli and when overexpressed in its native organism. Research into heme uptake 
in N. gonorrhoeae is extremely important. Iron is critical to the survival of many bacteria, and 
heme is an abundant potential iron source in the human host. Gonococci can utilize heme in the 
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absence of the hemoglobin receptor (31) and also in a TonB-independent manner (9, 88). Many 
organisms have dedicated heme receptors, such as Moraxella catarrhalis (33), Shigella 
dysenteriae (61), and Bordetella pertussis (62). It has been proposed that N. gonorrhoeae also 
has a dedicated heme receptor (53), however one has never been clearly identified. The 
meningococcal homologue of TdfJ, ZnuD, has been implicated in heme utilization (51). The 
meningococcal homologue has also been proposed as a vaccine target (44). Therefore, 
investigation into TdfJ’s role in heme uptake was warranted because little is known about this 
TBDT that has the potential to be an excellent vaccine target.  
 The first of the two hypotheses was confirmed, as TdfJ did bind hemin when expressed in 
E. coli from SS1 and SS2. However, when the hemin binding assay was performed in the 
gonococcal background the results were inconclusive. There are many potential explanations for 
the lack of a conclusive hemin binding phenotype when the assay was performed in the native 
organism. As aforementioned, N. gonorrhoeae have been shown to utilize heme in the absence 
of the hemoglobin receptor and in the absence of tonB. This indicates that there are redundancies 
in the organism’s ability to import heme. Without removing the other heme uptake pathways it 
would be difficult to see a heme binding phenotype because there are obviously other proteins 
binding heme in addition to TdfJ. This is likely why the levels of background hemin binding 
were so much higher when the assay was performed with N. gonorrhoeae rather than E. coli.  
 Surprisingly, TbpA was also able to bind hemin when expressed in E. coli. Although 
TbpA only contained the FRAP motif, and did not contain the conserved histidine residue or 
NPNL motif, inspection of a TbpA 2-D topology model revealed that there are 2 highly 
conserved histidine residues in surface exposed loops 2 and 11. These histidine residues may be 
involved in hemin binding. This unexpected result suggests the possibility that TbpA is a multi-
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factorial transporter. Interestingly, it has been suggested that TbpA participates in hemin 
utilization previous to this finding. In a gonococcal mutant unable to express TbpA, heme uptake 
was reduced by greater than 50% as compared to wild type heme uptake (7). In order to ensure 
that hemin binding was not an artifact of recombinant protein overexpression, a ribonuclease 
leakage assay was performed. The assay revealed that all of the E. coli expression strains used in 
the hemin sedimentation assay leaked RNase at various levels. This finding further supported the 
specificity of hemin binding to TbpA and TdfJ, and helped to rule out the possibility that 
membrane disruption was causing nonspecific sticking of hemin to the cells. 
 After recombinant TbpA and TdfJ were shown to specifically bind hemin, hemin binding 
blots were performed in order to assess their ability to bind hemin via a different method. The 
results were surprising because bands representing TdfJ and TbpA were not predominant. We 
expected that there would be bands corresponding to TbpA and TdfJ, but instead a hemin-
binding band of a different size resulted. Bands that could correspond to TdfJ and TbpA are 
present, however they are very faint. This was not discouraging because after SDS-PAGE, TbpA 
is unable to bind transferrin due to the loss of protein conformation. Also, the low intensity of the 
signals representing TdfJ and TbpA could simply correspond to lower levels of expression in 
general. The two dark hemin-binding bands, approximately ~35 and ~70 kD in size, were sent 
for protein identification. Protein identification from a 1D gel can be tough because parts and 
pieces of many different proteins can be found in one band. However, the results for the 
identification of the smaller hemin-binding band were fairly clear. The ~35 kD protein was 
putatively identified as FbpA. FbpA is the periplasmic binding protein responsible for shuttling 
the iron released by the transferrin and lactoferrin acquisition systems across the periplasm. As 
previously mentioned, this periplasmic protein was likely included in the sarkosyl insoluble outer 
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membrane preparation because apo-FbpA binds directly and specifically TbpA (80). This is 
interesting because it is the second protein involved in the transferrin acquisition system that was 
implicated in heme binding. This could indicate that the pathway used to import iron from 
transferrin could also be used to import heme, thus suggesting that the transferrin acquisition 
system has broad specificity. Until this point, the transferrin acquisition system was only known 
to have one substrate. 
 The protein identification results for the larger, ~70 kD band, were less clear. Many 
things were detected in the band, including TbpA and Porin, however the best matches were to 
PilQ and FetA. PilQ functions in type IV pilus organelle biogenesis (29), and FetA is the TBDT 
responsible for the import of ferric enterobactin and other catecholate-type siderophores (14, 43). 
Interestingly, it has also been suggested that FetA participates in hemin utilization previous to 
this study. In a gonococcal mutant unable to express FetA, heme uptake was reduced by greater 
than 50% as compared to wild type heme uptake (7). PilQ has also been previously implicated in 
heme uptake. PilQ forms a channel that allows for the entry of heme and antimicrobial 
compounds (22). A mutation within PilQ resulted in increased heme entry. However, a strain 
lacking both PilQ and the hemoglobin receptor were still able to grow on free heme, so there is 
obviously another mechanism for entry (22). These results indicate that there may be many 
players involved in heme binding and uptake. The hypothesis that there is one discrete heme 
uptake system in N. gonorrhoeae was disproved by these studies. There are likely additional 
proteins involved in hemin binding and uptake that have yet to be identified. Information 
provided by this study will possibly help to elucidate other heme uptake pathways.  
 Together, the results from all of the aspects of this study increase the knowledge base 
associated with gonococcal TBDTs. The data provided in this study offers valuable insight into 
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the pathogenesis of N. gonorrhoeae and could aid in the development of a vaccine or new 
therapeutic agents. The development of effective new therapeutics or a vaccine would greatly 
benefit public health. Although gonorrhea has long been a treatable disease, the ability to easily 
fight this pathogen is waning. Antibiotic resistance is on the rise and will continue to be a 
problem in the future. If the issue is not dealt with, gonorrhea could become untreatable. This 
would be very problematic for human health, and especially for women’s health. Downstream 
sequelae resulting from untreated gonococcal infection are numerous, including detrimental 
effects for reproductive health. Infections and their resulting symptoms are costly to the economy 
and burden the healthcare system. These costs will only increase as the infection becomes more 
and more difficult to treat. As previously mentioned, TBDTs make excellent vaccine targets 
because they are surface exposed, well-conserved, and provide nutrients that are essential for 
bacterial survival. This is why knowledge pertaining to their structure, function, expression, and 
regulation is important to attain.  
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